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by 
Katie A. Johnson 
Spring 2020 
The outcomes of novel host-pathogen interactions are unpredictable but can result in 
epidemics or pandemics. Exploring the initial encounter between a pathogen and a novel 
host species can elucidate why some pathogens successfully infect and adapt on a novel 
host when others fail. Much of our understanding of host virulence after host shifts was 
developed using serial passage experiments (SPEs) in bacteria. Three accepted SPE 
generalities have emerged: virulence increases on the novel host, the evolved pathogen 
will become less able to infect its native host, and the pathogen experiences convergent 
evolution. This study tests the first two generalities using complex hosts (Drosophila sp) 
and the highly virulent Drosophila C virus (DCV). The fitness of DCV was utilized as a 
proxy for virulence (pathogen’s harm to host) and investigated over 10 serial passages of 
the pathogen. The number of eggs, pupae, and adults were measured along with the days 
to pupation and to adulthood. We observed significant decreases in fecundity for both 
hosts but no significant effects on developmental metrics. The novel host experienced a 
significantly larger decrease in survivability than the native host. This decrease in 
fecundity and increases in mortality indicate an increase in DCV virulence on the novel 
host. Viral load does not explain the increase in virulence. The virus evolved on the 
native host was equally virulent to the native host as the ancestral virus, in contrast to 
SPE predictions. This study supports the SPE generality of increased virulence in the 
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CHAPTER ONE 
Emerging diseases: a review of influences and mechanisms of a host shift 
Introduction 
With the world currently in the middle of a pandemic due to the novel 
coronavirus, SARS-CoV-2, the need to predict and prevent future host shifts has never 
felt more necessary (CLEAVELAND et al. 2001; HOWARD and FLETCHER 2012). Studying 
the initial encounter of a pathogen with a novel (new) host can provide insight as to why 
some pathogens can successfully evolve to infect a novel host (host shit) when others fail 
(HOBERG and BROOKS 2015). Additional knowledge of host shifts can lead to medical 
and agricultural benefits such as better vaccine design, prevention of deadly diseases, and 
diminish current virulent pathogens (BULL 1994). COVID-19 alone has led to a 
detrimental shortage of healthcare supplies, a monumental economic crisis, and 
thousands of deaths all within a matter of months. This being due to just one successful 
host shift event (CORONAVIRIDAE STUDY 2020). Discussed here are the environmental 
and ecological factors that can accelerate host shifts along with the coevolutionary 
processes between a pathogen and host. The benefits of the model organism Drosophila 
fruit flies and the Drosophila C virus are also covered including methods of analyzing 
virulence evolution. This system can be used in the hopes to better understand the critical 
interactions that occur at the initial stages of a host shift.  
Host Shifts Resulting in Emerging Diseases 
Emerging infectious diseases, characterized as previously unknown infections or 
those moving into a new environment, have caused widespread illness in humans, plants, 
and animals (HOWARD and FLETCHER 2012). A sudden emerging disease currently 
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threatening the world is coronavirus disease 2019 (COVID-19) caused by a novel 
coronavirus named SARS-CoV-2. Coronaviruses normally have an animal reservoir and 
cannot infect humans, however, COVID-19 along with the cases of middle eastern 
respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS) are proof 
the transition is possible. With little to no immunity among the novel host population the 
ability to spread worldwide (referred to as a pandemic) is greater. Upon comparison of 
the genomic sequences of SARS-CoV-2 between the United States and China, the 
similarities suggest the pandemic emerged from a single event. Even though most 
pathogens cannot evolve to infect a new host, SARS-CoV-2 is an example of the extreme 
effects just one successful host shift can have (CORONAVIRIDAE STUDY 2020). For this 
reason, it is important to further analyze how these, and other pathogens, made the shift 
along with the processes that can influence these events. 
Ecological disturbances from human intervention or natural phenomena have 
influenced encounters with novel hosts. These include but are not limited to climate 
change, human encroachment, and agricultural practices which can assist the pathogen in 
filling new environmental niches (PATZ et al. 2000; HOBERG and BROOKS 2015). New 
host-pathogen interactions can result in unpredictable host switching opportunities and 
the possibility of widespread infection (epidemics) (HOBERG and BROOKS 2015). 
Zoonoses in particular, pathogens transmitted from animal species to humans, have 
become an increasing public health concern (WOOLHOUSE and GOWTAGE-SEQUERIA 
2005). Besides from the most recent COVID-19 pandemic, the world has faced the 
consequences of many other zoonotic events. Hantavirus outbreaks from rodent exposure, 
the 2009 H1N1 pandemic, the 2003 epidemic of SARS, the continuing fight against 
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human immunodeficiency virus (HIV), and many other pathogens that evolved from 
animal hosts have had an impact on human health (HOWARD and FLETCHER 2012).  
Host-pathogen evolution is not limited to zoonoses. High mortality rates within 
livestock and the agricultural industry have also had a strong socio-economic impact 
(CLEAVELAND et al. 2001). For example, bananas and plantains are one of the world’s top 
five staple crops but farmers are currently facing the Sigatoka disease complex, the most 
deadly banana disease seen worldwide (CHANG et al. 2016). For these reasons, pathogens 
with the ability to infect multiple hosts are of importance. Examination of their host shift 
mechanisms and viral-pathogen responses can provide key insights (HOWARD and 
FLETCHER 2012; CHANG et al. 2016).  
Host Shift Mechanisms 
Evolutionary biologists have attempted to understand the dynamics of emerging 
diseases in order to hypothesize why and how certain pathogens can shift from their 
native host to a novel host (CLEAVELAND et al. 2001; ALIZON et al. 2009). A pathogen 
faces numerous obstacles when invading a new host. The dynamic process of the host’s 
attempt to eradicate the pathogen coupled with the pathogen’s attempt to utilize the host 
for survival are discussed here (CHERRY and PERRIMON 2004). There are three main steps 
to a host shift: 1) exposure to a novel host 2) infection of the host 3) transmission to other 
hosts within the population. Throughout these steps there are multiples factors that can 
influence whether or not the pathogen is successful (LICHT 2018). 
An initial hurdle a pathogen faces is survival in the new environment. This may 
require a novel defense mechanism to fight off enemies not previously encountered. They 
may also need to develop other ways to survive in these harsh conditions (HOBERG and 
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BROOKS 2015). Additionally, the pathogen is faced with the host’s immune response as it 
tries to adhere, invade, and exploit the host’s replication pathway (LINDE et al. 2015). 
The innate immune system provides the first line of defense for metazoans and shapes the 
subsequent adaptive immune response within vertebrates (SABATIER et al. 2003; 
GALIANA-ARNOUX et al. 2006b). For instance, if structures of the pathogen bind to 
pattern recognition receptors (PRRs), the host’s immune system will respond by killing 
the organism through direct phagocytosis, toxin production, or cytokine release 
(SABATIER et al. 2003). The pathogen must be able to evade or suppress the host’s innate 
immune response in order to survive and ultimately replicate (CHERRY and PERRIMON 
2004; VAN SLUIJS et al. 2017). Lastly, for pathogenic offspring to persist, vital nutrients 
must be effectively utilized by exploiting the host (HOBERG and BROOKS 2015). 
Pathogens use several methods to bypass these host defenses (ELLISON et al. 
2017). Herpes simplex virus 1 (HSV-1), for example, can cause recurrent infection by 
targeting certain aspects of the innate and adaptive immune system. The viral 
glycoprotein gE of HSV-1 can impair antibody responses by binding to the IgG Fc 
domain. Additionally, glycoprotein gC can bind to C3b which plays an important role in 
compliment activation along with other molecules to assist HSV-1 in evading the host’s 
immunity (LUBINSKI et al. 1999). Since the advances of molecular techniques, specific 
genetic adaptations may be identifiable, however, individual host-pathogen interactions 
produce variable outcomes. This variability makes them not only difficult to predict but 
also suggests diverse environmental and genetic factors play a key role within pathogen-
host coevolution (DUNEAU et al. 2017; VERTACNIK and LINNEN 2017). 
Ecological Pressures on Host Shifts 
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 The risk of an emerging disease can be influenced by environmental pressures 
placed on a pathogen-host interaction (CLEAVELAND et al. 2001; DESJARDINS et al. 
2017). Ecological disturbances, both natural and human caused, can alter the overall 
balance of the community (PATZ et al. 2000; MORLEY et al. 2015). Significant examples 
of human drivers that can lead to an imbalance include encroachment on wildlife, 
urbanization, deforestation, and altered land use (PATZ et al. 2000). Humans can 
influence the density of the host, the pathogen, or the vector which can in return increase 
interactions or even encourage novel associations (ROGALSKI et al. 2017). A sharp 
increase in the cases of arenavirus in humans was a historical demonstration of the health 
consequences caused by agricultural practices. The increase in agricultural crops 
influenced an increase in rodent populations. This amplified the contact between humans 
and rodents which ultimately supported an increase in transmission of the zoonotic 
disease (DOMINGO and HOLLAND 1997).  
The more recent ease of travel, especially by air, has caused population mixing 
(introduction of host with parasite). This mixing can impact the pathogenicity of the 
parasite and encourage rapid transmission to new hosts (HOWARD and FLETCHER 2012; 
GOMEZ et al. 2015). A noteworthy example from 2003 was the introduction of SARS to 
new areas by air travel. It took just 1 week to introduce SARS to 17 additional countries 
(HOWARD and FLETCHER 2012). At the start of COVID-19, restrictions on travel was a 
vital action taken in hopes to decrease the potential of a pandemic. 
We are also currently living in a time of accelerating climate warming. Climate 
change in both the sporadic and gradual context can force community fluctuations by 
straining native species’ growth. The fluctuation can simultaneously allow novel hosts to 
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fill the void (PATZ et al. 2000). Scientists are coming to the realization a better 
understanding of host shifts can be reached through the study of historical events coupled 
with continual monitoring of the ecological impacts. While human disturbance and 
natural phenomenon will continue to influence pathogen-host interactions, putting more 
effective air travel and physical perturbation restrictions in place can help prevent future 
incidences (HOWARD and FLETCHER 2012; HOBERG and BROOKS 2015).  
Genetic Pressures on Host Shifts 
On a molecular level, an evolutionary arm’s race between the host and pathogen 
occurs. This race can drive adaptations in the pathogen which can alter its fitness 
(CLEAVELAND et al. 2001; LONGDON et al. 2018). The likelihood of a successful shift 
first relies on exposure of the pathogen to the novel host. The second factor includes the 
underlying genetic compatibility. Recognizing their impact can help in the predictions of 
host jumps (PARKER and GILBERT 2004; CHANG et al. 2016). Phylogeny studies have 
shown an increased tendency of a host shift to occur if the species are closely related, 
referring to the process as ‘ecological fitting via resource tracking’ (LONGDON et al. 
2015; LICHT 2018; LONGDON et al. 2018). Closely related species have shown parallel 
genetic changes, referred to as convergent evolution. This evolution suggests a pathogen 
that has successfully adapted to a host, is now better adapted to other closely related hosts 
(CHANG et al. 2016; LONGDON et al. 2018).  
While some species may be pre-adapted to evolve to infect a new host, numerous 
experimental findings support the idea that a majority of genetic variation takes place 
during the host shift process (LONGDON et al. 2018). The ability of a pathogen to adjust to 
a novel host that contains resources not previously encountered is thought to rely on the 
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extent of genetic plasticity (LICHT 2018). The plasticity involves the ability to increase 
fitness on the novel host by producing an adapted phenotype from a genotype previously 
hidden by natural selection. RNA viruses, in particular, can have large genetic diversity. 
They have higher rates of mutation due to the proofreading inability of RNA polymerase. 
This means each mistake the enzyme makes goes unfixed. The mutations have benefited 
the pathogen’s ability to establish infection in a new host. For instance, the avian 
influenza virus accumulated mutations which allowed for better binding and RNA 
polymerase activity within mammalian cells (LICHT 2018).    
RNA viruses are especially prone to becoming an emerging disease due to their 
high genetic plasticity and short replication times (DOMINGO and HOLLAND 1997; 
CLEAVELAND et al. 2001; DUFFY et al. 2008; HOWARD and FLETCHER 2012). They 
produce genetic variation by forming mutant swarms of RNA viruses known as 
quasispecies. The quasispecies can be produced through mutations, genome segment 
sorting, and recombination. The variation equips them with a higher probability of filling 
new niches (DOMINGO and HOLLAND 1997; DRAKE and HOLLAND 1999; CLEAVELAND et 
al. 2001). Complex hosts, such as humans, evolve at a much slower rate than RNA virus 
pathogens. For this reason it seems the host would not be able to keep up with the 
pathogen’s evolution allowing the viral infection to go uncontrolled, however, this is not 
always the case (SHIN and MACCARTHY 2016). Humans contain superior defense 
mechanisms suggesting host shifts are multifaceted and the study of genetic factors alone 
does not have the ability to predict pathogen expansion (SHIN and MACCARTHY 2016; 
VERTACNIK and LINNEN 2017). 
Evolution of Virulence 
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While evolutionary biologists have studied parasite-host co-evolution for decades, 
the ability to predict whether a host shift will result in a major outbreak versus going 
relatively unnoticed has proven a difficult task (LEVIN 1996; BRUSINI et al. 2013). When 
studying the shift of Ebola virus, HIV, and SARS virus, an increase in pathogen virulence 
(the pathogen’s degree of harm to host) was noted following each host shift (ALIZON et 
al. 2009). Virulence can sometimes be a consequence of pathogen replication or from 
infecting tissue that has no adaptation value to the pathogen. Some pathogens that are 
found to be largely asymptomatic in the native host, but can be deadly to the novel host 
(LONGDON et al. 2015). For instance, the virus SARS-CoV naturally demonstrates little 
to no signs of infection in bats, its reservoir host, but the virus can cause severe 
respiratory symptoms in humans (WATANABE et al. 2010). These findings have lead 
scientists to believe there is a strong correlation between virulence evolution and host 
shift severity, but little is still known (LONGDON et al. 2015).  
There have been several hypotheses proposed surrounding virulence evolution. 
Logic initially supported the idea that a fully evolved pathogen would not want to kill its 
host too quickly. If the host dies immediately, the pathogen may not be able to fully 
exploit the host’s resources or successfully transfer to a new host (REGOES et al. 2000). 
The avirulence hypothesis was born from this idea, specifically suggesting a parasite 
evolves towards an end goal of harmless co-existence (LEVIN 1996; JANSEN et al. 2015). 
The avirulence hypothesis became so accepted that many referred to it as ‘conventional 
wisdom’ (ALIZON et al. 2009). With only a few systems to support these claims, and the 
fact that not all evolved pathogens have been shown to become less virulent over time, a 
more recent hypothesis arose (MAY and ANDERSON 1983).  
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After a period referred to as ‘enlightenment’ in 1980, a new idea surrounding 
virulence evolution was proposed. It was developed in 1982 and 1983 by R. M. May & 
R. M. Anderson and Paul W. Ewald, respectively, known as the trade-off hypothesis 
(EWALD 1983; MAY and ANDERSON 1983; ALIZON et al. 2009). The hypothesis 
suggested a series of trade-offs occur between the pathogen’s level of virulence and 
transmission rate (EWALD 1983; ALIZON et al. 2009). For instance, with high levels of 
virulence a positive outcome of rapid and vigorous host exploitation occurs, but could 
lead to host death before the pathogen can successfully spread within the host population 
(FRANK 1996; ALIZON et al. 2009). One of the most recognized early models supporting 
the claim of host-parasite coevolution was the use of myxoma virus to control European 
rabbit populations. A highly virulent strain of myxoma virus was released, killing most of 
the rabbit population quickly. The highly virulent strains were at a disadvantage because 
they killed the host too quickly, but the strains that were too attenuated did not produce 
enough lesions which limited the virus’ spread to the rest of the population. The virus that 
was later recovered from the rabbit population had a lower virulence and transmission 
rate than the starting myxoma virus but was still significantly more virulent than the 
viruses attenuated within the laboratory setting. This experiment supported the 
enlightenment theory that natural selection could select and still maintain virulent strains 
instead of just evolving to become more avirulent. It provided evidence of a trade-off 
between transmission and virulence (LEVIN 1996).  
As more examples of coevolution were reviewed, there was a realization that 
while the trade-off hypothesis could teach us important information about host shifts, it 
was still too simplistic to fully explain virulence evolution (ALIZON et al. 2009; 
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LONGDON et al. 2015). The variability of virulence between different pathogens 
suggested parasite evolution is influenced by more than just transmission rates and 
virulence levels (MACKINNON and READ 2004). In 1996 Steven A. Frank proposed 
additional trade-offs that may also greatly impact the coevolution. The trade-offs 
included competition for the same resources (tragedy of the commons) and within-host 
competition (FRANK 1996). Additional implications were made for the diversity of the 
host population (heterogenous vs homogenous) and immunity (resistance vs tolerance 
mechanisms) (REGOES et al. 2000; MACKINNON and READ 2004; BEST et al. 2014). The 
original hypotheses behind the evolution of virulence relied heavily on theoretical 
mapping and examination of ‘natural systems.’ While virulence has been widely 
recognized as an important component of host shifts, the mechanisms behind this 
evolution is still relatively unknown (ALIZON et al. 2009; LONGDON et al. 2015). 
However, the knowledge of genetic and ecological mechanisms involved with virulence 
evolution has since progressed through the use of serial passaging experiments and 
molecular advances (EBERT 1998; LONGDON et al. 2015). 
Serial Passaging Experimentation 
 Serial passaging experiments (SPEs) have been used to make vaccines through 
pathogen attenuation. SPEs have also become a powerful tool for evolutionary biologists. 
(EBERT 1998). During a SPE the pathogen is transferred from one host to the next while 
observing the evolution characteristics over time (EBERT 1998). SPEs can allow for the 
adaptation to a new host within a matter of days. The experiment can also allow for 
control of certain aspects within the environment, transmission mode, viral load, and 
genetic diversity, amongst other factors (EBERT 1998). Having the ability to control 
11 
 
certain aspects of the host-pathogen interaction can allow researchers to come to more 
definitive conclusions (ALIZON et al. 2009). Many changes in virulence have attributed to 
mutations or other recombinant events during the passaging process. For this reason, 
SPEs that can be coupled with gene expression analysis technology have provided 
important insight on the molecular mechanisms behind host shifts (LINDE et al. 2015). 
New technology has even allowed for these genetic adaptations to be analyzed in real 
time (VANGUILDER et al. 2008; LINDE et al. 2015).  
The trade-off hypothesis has been under critical review since it was originally 
proposed. It utilized the observation approach (collecting specimens from nature and 
analyzing trait pairs) along with the comparative approach (larger pooling of specimens) 
(ALIZON et al. 2009). Since utilization of the experimental approach the most compelling 
data on changes associated with coevolution has been discovered (ALIZON et al. 2009; 
LONGDON et al. 2015). For instance, rapid shifts in pathogen virulence have been 
documented in H5N2 avian influenza virus after just one serial passage in mice. This 
experiment showed alterations of two amino acids were responsible for the increased 
pathogenicity (NAM et al. 2017). Serial passaging of the bacteria Corynebacterium 
pseudotuberculosis similarly demonstrated changes in gene expression allowing the 
bacterium to evade the novel host’s immune system and increasing virulence (SILVA et 
al. 2017). While altered resistance and virulence over time have been a paralleled finding 
in more recent coevolution SPEs, a full understanding of the role of viral loads, the 
diversity of host and parasite, the specificity of the parasite, etc., play on genetic 
adaptations has not been obtained (DENNEHY et al. 2006; LITTLE et al. 2006; BETTS et al. 
2018; BONNEAUD et al. 2018).  
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A key component of emerging and re-emerging diseases relies on successful 
transmission to new hosts, making it a focus for SPEs (VAN DEN BOSCH et al. 2010; 
ANTONOVICS et al. 2017). There are two modes of transmission: vertical and horizontal 
(ANTONOVICS et al. 2017). Vertical transmission involves a transfer of the pathogen from 
parent to offspring via reproduction, while horizontal transmission includes transfer of 
infection from the environment (direct or indirect) (VAN DEN BOSCH et al. 2010; LE 
CLEC'H et al. 2017). A trade-off between the two modes of pathogen transmission are 
believed to occur when infecting and adapting to a new host (VAN DEN BOSCH et al. 2010; 
LONGDON et al. 2011b). Ecological theory predicts vertical transmission alone will result 
in lower virulence while horizontal transmission needs to maintain a higher level of 
virulence (LIPSITCH et al. 1995; LIPSITCH et al. 1996; LE CLEC'H et al. 2017). This theory 
supports the idea that horizontal transmission can cause rapid increases in virulence. The 
unregulated effects of horizontal transmission utilizing Wolbachia, an endosymbiont 
bacteria, with a native host that is normally unaffected by Wolbachia is an example of 
this theory (LE CLEC'H et al. 2017). After a few serial passages of Wolbachia the bacteria 
evolved from unharmful to a true pathogen to the native host. Similar horizontal 
transmission findings were discovered using the intracellular bacterium Coxiella burnetii 
(LE CLEC'H et al. 2017).  
Previous research within the Matos laboratory has focused on the Drosophila fruit 
fly model and Sigma virus, a vertically transmitted and mildly virulent RNA virus, to 
study the early stages of a host shift ((HENDRIX 2018; MONSANTO-HEARNE and JOHNSON 
2018). In that work, the Sigma virus was passaged naturally (vertically) within the fly 
populations for 20 fly generations. Although virulence did increase on the novel host (as 
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predicted), the virus did not evolve. It is possible that the vertically transmitted nature of 
the Sigma virus produced a natural bottleneck that selected for a particular viral genotype 
(BRUSINI et al. 2013). Further work in the Matos lab suggested that host immunity may 
also play a key role in how the novel host responds (HENDRIX 2018). Therefore, the low 
virulence of Sigma virus mixed with the known host response and the vertical nature 
(transovarial) of the virus may have confounded the results. Future studies could benefit 
from investigation of the pathogen evolution following a host shift when the pathogen is 
highly virulent and horizontally transmitted. 
Drosophila as a Model Host 
Model systems have long been used as a simple and effective way of studying 
underlying evolutionary mechanisms with the ability to apply findings to more complex 
models (VAN SLUIJS et al. 2017). The Drosophila fruit fly is an extensively studied 
complex multicellular organism used as a model system for over a century (ADAMS et al. 
2000; BIER et al. 2018). Many of the antiviral defense responses have been conserved 
between Drosophila and invertebrates making them a useful model for evolutionary 
studies (OSBORNE et al. 2009). Since Drosophila was chosen as a model organism in 
1990 for the Human Genome Project, it has become an important tool for genetic 
research also (ADAMS et al. 2000; CLARK et al. 2007). The genetic components of 
Drosophila have been well-characterized allowing much of their development, metabolic 
processes, and innate immune system responses to be applied to biological processes in 
vertebrates (SABATIER et al. 2003; PONTON et al. 2011). Tools such as FlyBase, 
GenBank, FlyAtlas, and protein-interaction maps provide not only the Drosophila 
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genomic sequence but also the ability to parallel human genetic diseases (GIOT et al. 
2003; CHINTAPALLI et al. 2007; CLARK et al. 2007; PONTON et al. 2011). 
Additional advantages of Drosophila include the ability to easily collect wild 
populations. These species can be used for laboratory experiments, specifically viral 
pathogenicity research due to their ability to be infected with over 30 viruses in nature 
(VAN SLUIJS et al. 2017). Drosophila melanogaster can be infected with human 
pathogens including West Nile virus and Sindbis virus (VAN SLUIJS et al. 2017). Lastly, 
the organism has a relatively small genome (~180 megabases) making molecular 
techniques less costly than mice or other complex models (ADAMS et al. 2000). 
Horizontal transmission of Drosophila C virus using Drosophila melanogaster as the 
native host and Drosophila mauritiana as the novel host can provide genetic and 
virulence evolution information that can be applied to other host-pathogen systems. 
Drosophila C Virus as a Model Pathogen 
Drosophila C virus (DCV) is a nonenveloped, positive-sense, single-stranded 
RNA virus. It is a member of the Dicistroviridae family originally isolated in the French 
Charolles strain of Drosophila melanogaster in the 1970s (JOUSSET et al. 1977; 
SABATIER et al. 2003). It is one of the most highly studied Drosophila viruses making it a 
good model pathogen (GALIANA-ARNOUX et al. 2006b; OSBORNE et al. 2009). DCV is 
endemic among Drosophila melanogaster meaning it has coevolved with this species. 
There are numerous species of Drosophila DCV is not normally found to infect in nature 
but can cause infection in a laboratory setting such as Drosophila mauritiana. For this 
reason, DCV can be used for host shift experiments using closely related species. DCV is 
an even more suitable tool for evolution research due to the high mutation rates of RNA 
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viruses which results in high genetic diversity (DUFFY et al. 2008). It also has not been 
found to shift to humans, making it safe to work with in the laboratory setting (LONGDON 
et al. 2015).  
The pathogen is naturally spread by horizontal transmission through ingestion or 
close contact. Microinjection can be utilized in order to achieve artificial infection. The 
injection process allows for horizontal transmission with no significant effects on the 
species (CHERRY and PERRIMON 2004). It is also highly virulent even to the native host 
causing infected flies to die within 4-6 days (SABATIER et al. 2003; OSBORNE et al. 2009). 
Vertebrate picornaviruses closely resemble DCV so studying the interaction of 
Drosophila mauritiana and melanogaster with DCV can uncover infectious mechanisms 
relative to human pathogens such as poliovirus and foot-and-mouth disease (CHERRY and 
PERRIMON 2004). For example, studies have indicated a subset of genes that are induced 
by DCV. These genes are regulated by the Jak-STAT pathway which was initially found 
in mammals for interferon signaling (part of the innate immune response). The results 
suggest some mechanisms for responses to infection are evolutionarily conserved 
(GALIANA-ARNOUX et al. 2006a). 
Changes in Fecundity/Fitness as an Indication of Host Response 
 While Drosophila cannot mount an adaptive immune response, they do have an 
innate immune system that is like that of other complex organisms. For this reason, host-
pathogen interactions using Drosophila have been well studied (Galiana-Arnoux et al., 
2006). Research has indicated Drosophila species have the ability to fight off some 
infections enough to survive, but the deployment of the innate immune response may 
impose a cost on components of host fitness (AHMED et al. 2002). The immune response 
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cannot be effectively deployed while maintaining all fitness aspects. This means fighting 
off the infection can come as an indirect cost to fitness (MORET and SCHMID-HEMPEL 
2000). The cost of survival can result in decreases in fecundity believed to be a coping 
mechanism. During a SPE the changes in fitness through measures such as fecundity and 
mortality can then be correlated with changes in pathogen virulence. In theory, the more 
virulent the pathogen, the lower the host fecundity. This proxy for virulence is an easier, 
more visual method of measuring virulence evolution which can then be paired with such 





Drosophila C virus virulence increased after a host shift and serial passage in Drosophila 
hosts 
Introduction 
Pathogen host-shifts can dramatically affect the world: this was plainly evident 
with the host shift of SARS-CoV-2 into humans in 2019. The novel coronavirus disease-
2019 (COVID-19) quickly reached pandemic status; filling hospitals with patients, 
causing businesses to close, and influencing unprecedented lifestyle changes around the 
world. While COVID-19 has been the most disruptive host-shift event of the last 100 
years, it is not the only novel pathogen we’ve seen in that time. Among recent examples 
are severe acute respiratory syndrome (SARS, 2002), middle eastern respiratory 
syndrome (MERS, 2012), and human immunodeficiency virus (HIV, 1981) (SHARP and 
HAHN 2011; CORONAVIRIDAE STUDY 2020). Each of these pathogens was able to shift 
from an animal reservoir to a human (WOOLHOUSE and GOWTAGE-SEQUERIA 2005). 
These shifts into humans are known as zoonoses. Luckily most pathogens cannot 
successfully effect a zoonotic event because these are low odds events with numerous 
factors influencing the process (LICHT 2018).  
There are three main steps to a host shift by a pathogen: 1) pathogen exposure to a 
novel host species, 2) successful infection of the novel host, and 3) pathogen transmission 
to other hosts within the population. The likelihood of a successful shift to a novel host 
first relies on exposure of the pathogen to the novel host. An initial hurdle a pathogen 
faces is survival in the new environment (PARKER and GILBERT 2004). Additionally, the 
pathogen is faced with the host’s immune response as it tries to adhere, invade, and 
exploit the host’s replication pathway (LINDE et al. 2015). The pathogen must evade or 
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suppress the host’s response in order to survive and replicate within the host (CHERRY 
and PERRIMON 2004; VAN SLUIJS et al. 2017). Once vital nutrients are effectively 
obtained by exploiting the host, transmission to the next host must be completed 
(HOBERG and BROOKS 2015). If the exploitation occurs too rapidly the host dies before 
transmission can occur (FRANK 1996). These obstacles have strong selective pressures 
which can ultimately lead to rapid pathogen adaptation (PARKER and GILBERT 2004). 
Phylogeny studies indicate an increased likelihood of a host shift to occur if the 
native and novel host species are closely related, referring to the process as ‘ecological 
fitting via resource tracking’ (LONGDON et al. 2015; LICHT 2018; LONGDON et al. 2018). 
This type of ecological fitting is possible when the pathogen, upon introduction to the 
novel host, is readily able to cause infection. If the novel host is genetically comparable 
to the native host, the pathogen has little to no new obstacles to overcome in order to shift 
to the novel host (LICHT 2018). Closely related species have shown parallel genetic 
changes, referred to as convergent evolution, which suggests there are key changes to 
molecular pathways in order to increase virulence (CHANG et al. 2016; LONGDON et al. 
2018). These results suggest an understanding of both the ecological and genetic 
influences on host shifts are necessary to better predict and prevent future occurrences. 
While studying host shifts, a common change in virulence (pathogen’s harm to host) has 
been noted. There appears to be an increase in virulence immediately following a shift to 
a novel host. These findings lead scientists to believe there is a strong correlation 
between virulence evolution and host shift severity (ALIZON et al. 2009). Studying host 
shifts and virulence evolution, is commonly performed using serial passaging 
experimentation (SPEs) where the pathogen is transmitted from one host to the next. 
19 
 
Three long-held generalities emerged from classic SPE studies: 1) the pathogen will 
increase in virulence on the novel host, 2) the evolved pathogen will be less able to infect 
the native host, 3) and the pathogen will experience convergent evolution (BULL 1994; 
EBERT 1998). Many of these SPE studies were completed using bacterial hosts and phage 
pathogens. This experimental approach can give fast results and allows for many 
passages, but bacteria may not show the same response to a novel pathogen that might be 
exhibited by a more complex host. Additionally, the pathogens used tend to have low 
virulence on the native host (BULL 1994). In the current study, we investigate pathogen 
evolution following a host shift by a highly virulent pathogen (Drosophila C virus) and a 
complex host (Drosophila sp.).  
Drosophila sp. are ideal hosts for SPE studies for several reasons. They are 
inexpensive to house and they can be kept in large numbers in an incubator. This 
provides the ability of larger sample sizes. Drosophila contain an innate immune 
response which is physiologically similar to the human response. The antiviral defense 
responses between Drosophila and vertebrates are particularly similar (ADAMS et al. 
2000; BIER et al. 2018). Findings from Drosophila have therefore been utilized to gain a 
better understanding of basic biological functions of mammals (PONTON et al. 2011). 
Drosophila can also be artificially infected with pathogens via microinjection allowing 
for controlled horizontal transmission.  
Drosophila C virus, a single-stranded RNA virus, is highly virulent and first 
discovered in D. melanogaster, killing the flies within 4-6 days. DCV can also infect 
others species of Drosophila within a laboratory setting via artificial infection (GALIANA-
ARNOUX et al. 2006b; OSBORNE et al. 2009). The RNA virus is made up of roughly 9,264 
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nucleotides with 2 non-overlapping open reading frames: ORF1 and ORF2. ORF1 
encodes for a polypeptide involved in replication while ORF2 encodes the second 
polypeptide containing 4 structural proteins that form the capsid. DCV produces genetic 
variation by forming mutant swarms known as quasispecies, seen especially in RNA 
viruses. The short generation time, high pathogen virulence, and ability for the RNA 
virus to evolve quickly makes this an ideal system to study virulence evolution 
(DOMINGO and HOLLAND 1997; DRAKE and HOLLAND 1999; CLEAVELAND et al. 2001). 
The genetic and fitness evolution was compared between the native and novel 
host to identify any differential responses to DCV at the initial stages of a host shift. By 
utilizing horizontal transmission, the more virulent strains of DCV may be represented in 
the population when compared to vertical transmission (LIPSITCH et al. 1996). D. 
melanogaster (Emel) was utilized as our native host and D. mauritiana (Maur) as our 
novel host. This work included 10 passages (denovo infections of naïve native and novel 
hosts with virions extracted from flies infected in the previous passage) in order to test 
the three generalities. The viral fitness was examined (RT-qPCR) along with the host 
fitness (proxy for virulence) at passages 1, 5, and 10. The fecundity of both host species 
significantly decreased from passage 1 to 10, but the developmental times remained 
unchanged. This suggests DCV virulence increased but results from RT-qPCR analysis 
did not show a change in the viral titer for either host. The Maur-evolved DCV was 
injected into naïve native hosts to test the hypothesis that the novel evolved virus would 
be less able to infect the native host. The native host still showed significant decreases in 
fecundity, but developmental and survivability times did not change. Lastly, the viral 
quasispecies was to be sequenced at the beginning (un-evolved) and after 10 passages on 
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the native and novel hosts. The sequencing was not completed for the evolved virus due 
to the research restrictions put in place as a response to COVID-19. For this reason, the 
hypothesis of convergent evolution could not be tested.  
MATERIALS AND METHODS 
Fly Lines 
The two Drosophila fly lines for this experiment were received from the 
University of California San Diego Drosophila Stock Center. D. melanogaster was used 
as the native host due to DCV naturally occurring in the fly line and D. mauritiana as the 
novel host where DCV is not found in nature. Both the native and novel host were highly 
inbred contributing to little genetic diversity within each species (HENDRIX 2018).  
Fly Rearing 
Flies were reared in an incubator kept at a relative humidity of 70% and 
temperature of 24°C. The incubator was set to a photoperiod of 16:8 light:dark with 
periods mimicking external light and dark times to minimize fly disturbance during 
opening of the incubator. The fly colonies were maintained using standard narrow fly 
vials. Each plastic Genesee Scientific vial (www.geneseesci.com; CAT #32-120) was 
filled with 7 ml of Jazz-Mix (www.fishersci.com) cornmeal growth medium (prepared as 
per manufacturer’s recommendations). Once the vials were cooled, a few grains of 
baker’s yeast and 1/8 of a KimWipe® was inserted into the edge of the cornmeal growth 
medium. Each vial was plugged with a cotton ball. Fly lines were maintained by 
combining 5 male and 5 female flies per vial and leaving them to oviposit for 7 days. 




DCV Inoculum and Artificial Infection 
 DCV inoculum was donated by Dr. Tanya Miura from the Department of 
Biological Sciences at the University of Idaho. The inoculum received was prepared in 
cell culture using D. melanogaster cells. The inoculum was received at a concentration of 
2 x 106 Median Tissue Culture Infectious Dose (TCID50) units/mL. The inoculum was 
split into 200µl aliquots and stored at -80°C.  
Horizontal transmission was achieved by artificial injection. A 3.5” glass needle 
blank (www.drummondsci.com; CAS #3-000-203-G/X) was pulled by a Kopf Model 720 
vertical needle puller then attached to a Nanoject II Auto-Nanoliter injector 
(www.drummondsci.com). The needle was filled with physiological grade mineral oil 
(www.sigma-aldrich.com; CAS #8042-47-5) attached to the injector, then back-filled 
with either DCV inoculum or Schneider’s medium as the negative control.  
The first serial passage included injection of both the native and novel host with 
the DCV inoculum provided by Dr. Miura. A total of 240 female flies per host species 
were injected. An additional 5 flies per host were injected and frozen immediately at -
80C. These 5 flies were used later as the target and control calibration samples during 
analysis (Day 0 flies) for viral fitness analysis. These flies were 3 to 5 days old at the 
time of infection. For the injection procedure, the females were anesthetized on a CO2 
flow bed and injected with 59.8nl of DCV per fly. The injection site was within the third 
dorsal tergite. Additionally, 24 flies from each host species were injected with 59.8nl of 
Schneider’s medium as the negative control. After injection, each fly was placed in a vial 
with 7ml of cornmeal growth media. Each female was provided with a male from her 
respective species. The vials were capped with a cotton ball and placed in the incubator. 
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The 240 flies were divided into 3 viral lineages (72 flies per lineage) and maintained as 
replicates throughout the entirety of the serial passage experiment (10 passages in total). 
Mortality was monitored until the LT50 point, the time by which 50% of the 
DCV-injected flies died, was reached for each lineage or until 10 days, whichever came 
first. Once the LT50 was reached, all remaining live flies were collected and immediately 
frozen at -80C separately for each lineage. The 10 collected live flies from each viral 
lineage (3 lineages per host) at the LT50 point was then used to generate inocula for each 
lineage (3 experimental replicates) and used to start the next passage (in this instance 
passage 1 to passage 2) (Figure 1). The inoculum was produced by homogenizing the 10 
collected flies in Schneider’s medium followed by centrifugation (Appendix IV). The 
supernatant (containing DCV) was injected into naïve native and novel female hosts for 
each viral lineage to start passage 2. A total of 24 naïve female flies from each host were 
injected with freshly thawed Schneider’s medium at each passage used as the negative 
control. This process was repeated for serial passages 2 through 10 maintaining the 
lineage replicates for each host species. 
Each of the fitness passages (1, 5, and 10) had a total of 72 naïve female flies per 
lineage injected with the unique DCV inoculum per fitness passage (2 species x 3 
lineages x 72 flies = 432 flies injected per fitness passage). After the injection an 
uninfected male was added to the vial. All other passages followed the same procedure of 
injection and infected fly processing to make the new inoculum. The number of female 
flies injected with the DCV inoculums was also reduced as we did not need so many 
without the fitness analysis. The number of flies injected with the negative control 
remained the same at 24 female flies per host species. The number of female flies 
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injected with the each DCV inoculum was reduced to 48 flies per lineage for a total of 
168 flies injected per host species. In total, 3,792 flies were injected over the ten 
passages, 480 with Schneider’s medium and 3,312 with the unique DCV inoculums. 
Fly Fitness as Virulence Proxy 
 Fly fitness by means of impacts on egg production and development success 
(harm to host) were utilized as a proxy for DCV virulence at serial passages 1, 5, and 10. 
The number of eggs oviposited (fecundity) and number of adults emerging from those 
eggs in each respective vial were counted. Hatchability (proportion of eggs that hatched) 
was also determined. To determine fecundity and hatchability, immediately after 
injection with DCV or negative control medium, each fly was placed individually in a 
vial prepared as above. However, the food in the vial was tinted green (McCormick Food 
dye) to improve egg visibility. The flies were allowed to oviposit for 24 hours and the 
number of eggs on the green tinted media were then counted. After another 24 hour 
period, the number of unhatched eggs were counted to calculate hatchability (Figure 3). 
Subsequently, the number of days until the first pupa was observed and days until 
the first adult emerged were recorded. The number of total pupae were counted on day 10 
post infection for each vial. The number of males and females, and total adults were 
counted day 21 post infection. This allowed enough time for completion of the normal 
Drosophila life cycle, but not enough time for the offspring’s next generation to emerge 
as adults within the same vial. In addition to fecundity and development, the number of 
deceased flies were monitored every 24 hours post injection for 10 days or until the LT50 
point was reached. Shifts in the LT50 were inversely related to shifts in virulence. 
Evolved novel virus on native host 
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A separate passage was performed to test the generality that the evolved novel 
virus would be less able to infect the native host. The same methods of artificial injection 
were utilized as with serial passages 1 through 10. The main difference being only the 
DCV inoculums from the novel host (D. mauritiana) were used for injection into the 
native host (D. melanogaster). The inoculums were collected from the 3 lineages of the 
novel host at the end of passage 10 (Appendix IV). Once the native host females were 3-5 
days old, 72 female flies were injected with 59.8nL of the evolved novel host DCV 
inoculum for each lineage for a total of 216 DCV infected flies. An additional 24 female 
native host flies were injected with the Schneider’s medium control. The LT50 point was 
monitored every 12-24 hours immediately after injection and either until 10 days or the 
LT50 was reached. Fly fitness by means of egg production, development to pupae, 
number of pupae, days to adult, and number of adults were also collected in parallel to 
the information gathered during the fitness passages 1, 5, and 10. 
Viral Fitness  
 DCV fitness was measured by viral genome reverse transcription followed by 
quantitative polymerase chain reaction (RT-qPCR) which demonstrated the relative 
amount of viral RNA present at passages 1, 5, and 10 (Figure 2). Once the LT50 points 
were reached, 20 surviving flies were collected from each infected lineage and frozen at -
80°C. RNA isolation with TRIzol® reagent was then performed on each fly individually 
(20 replicates x 6 lineages x 3 passages = 360 samples total). Each fly was homogenized 
using a 1.5mL clean reusable Kimble® 749515-0000 Kontes® Pellet Pestles® Tissue 
Grinder in TRIzol® reagent. Once only wings and exoskeleton remained, the sample was 
mixed briefly by vortexing. Phase separation occurred after the addition of chloroform. 
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The upper aqueous phase was transferred to a fresh tube and isopropyl alcohol added. 
The sample was vortexed and centrifuged forming a white pellet. After washing the RNA 
pellet with ethanol, it was dissolved in DEPC-treated RNase-free water with RNase 
inhibitor (Appendix I). The RNA purity and concentration were determined using a 
NanoDrop™ Light spectrophotometer (www.thermofisher.com).  
Isolated RNA was reverse transcribed (RT) using the Promega GoScript™ 
Reverse Transcription System (www.promega.com; CAT #A5000). The isolated RNA 
was combined with random hexamer primers and nuclease-free water for a final volume 
of 5µl. The combination was heated in a 70°C heat block, chilled on ice, then centrifuged. 
In a separate tube, GoScript™ 5X reaction buffer, 2mM MgCl2, PCR nucleotide mix, 
recombination RNasin® ribonuclease inhibitor, GoScript™ reverse transcriptase, and 
nuclease-free water was combined for a final volume of 15µl. The 15µl reverse 
transcription mix was combined with the 5µl primer and RNA mix. Annealing and 
extending were completed followed by inactivation of the reverse transcriptase in a heat 
block (Appendix II).  
RT was followed by qPCR using Bio-Rad SsoAdvanced Universal SYBR® 
Green Supermix (www.bio-rad.com; CAT #1725271). Previously published primers 
(Forward: 5’-GACACTGCCTTTGATTAG-3’ and Reverse: 5’-
CCCTCTGGGAACTAAATG-3’) for DCV were used to quantify the viral RNA load 
(LONGDON et al. 2015). To ensure genomic RNA was amplified rather than messenger 
RNA, the DCV primer spanned the intergenic region of the viral genome (LONGDON et 
al. 2015). The Drosophila housekeeping gene RpL32 (Ribosomal protein L32), 
established by Longdon, et al. 2011, was used as a reference gene for the RT-qPCR 
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(Forward: 5’-TGCTAAGCTGTCGCACAAATGG-3’ and Reverse: 5’-
TGCGCTTGTTCGATCCGTAAC-3’). Each sample was run separately with DCV 
primers and RpL32 primers in three technical replicates for each (360 samples x 3 
technical replicates = 1,080 for each primer set). qPCR was performed on a Bio-Rad CFX 
Connect™ Real-Time System for 2 minutes at 95°C then 40 cycles at 94°C for 10 
seconds, 55°C for 30 seconds, and 72°C for 30 seconds (Appendix III). In order to 
estimate the RT-qPCR viral load values, the cycle threshold (Ct) values, the number of 
cycles for the flourescence to exceed the background, were determined. In order to 
estimate the relative quantifiation of the DCV viral load for each sample a housekeeping 
gene (RpL32) was used. This reference gene controlled for differences in sample quantity 
and gave a fold change of the DCV gene relative to the reference gene. All samples were 
also placed on the plates in a randomized order to account for plate effect. Comparing the 
Ct values of the housekeeping gene to the DCV gene for each sample provided a way to 
track changing viral titers from passage 1 to 10  (LONGDON et al. 2011a). 
Convergent Evolution Test 
 Genomic analysis of DCV from the initial inoculum and from DCV isolated after 
serial passage 10 was to be compared to determine whether DCV evolved, specifically by 
converging on a common genotype (Figure 2). Passaged viral RNA was a collection of 
50 surviving flies at the LT50 point from each viral lineage per host species (100 flies 
injected x 6 viral lineages). The 100 female flies were injected with 59.8nl of the DCV 
inocula from passage 10 for each host lineage. RNA from unpassaged (ancestral 
inoculum) and passaged virions was isolated using TRIzol® RNA purification (Appendix 
I). The cDNA product from each viral lineage (3 viral lineages per fly line = 6 samples) 
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along with the initial DCV inoculum was to be sequenced with a MinION device by 
Oxford Nanopore Sequencing Technologies. The MinION Direct cDNA Sequencing Kit 
SQK-DCS109 and MinION flow cell FLO-MIN106 (www.nanoporetech.com) were to be 
used to identify and quantify the full length, intact DCV genome (Appendix V). 
Additionally, given that PCR was not used, each molecule sequenced would have 
corresponded to genetic material from a unique virion genome, thus enabling the genetics 
of the quasispecies population to be determined.  
Custom primers were used for sequencing the genomic RNA without 
amplification and without using the Nanopore barcoding kit while successfully 
integrating with the Nanopore process. In order to sort each viral lineage during analysis, 
unique VPN primers were made to yield barcoded sequences. The primers included a 
DCV sequence from a conserved area of the genome, the VPN sequence from Nanopore, 
and a custom barcode in the order: 5’ VPN-Barcode-GSP 3’. The SSP primers also 
included the SSP sequence from Nanopore along with the same custom barcodes for each 
lineage and methylated ribonucleotides at the end in the order: 5’ SSP-Barcode-MG 3’ 
(Table 1). These primers were used during the reverse transcription and strand-switching 
step of the direct cDNA protocol. Native barcoding kits provided by Nanoporetech would 
have involved ligating dT tailed barcode adapters after the end-prep protocol. This differs 
from our process where the barcode is within the primers, added within the initial steps of 
the protocol, and does not require additional steps outside of the direct cDNA protocol. 
This was done to avoid an amplification step while coping with the low amount of 
starting sample RNA. The unique DCV sequence also allows for more specific binding to 
DCV virions only, rather than binding to all strands with polyadenylated ends. This could 
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have led to a higher number of host derived RNAs being sequenced. All sequencing steps 
were completed for the initial inoculum (un-evolved). Due to the disruption caused by 
COVID-19 the evolved Maur and Emel inoculums were collected and TRIzol purified 
but not sequenced with the MinION device. For this reason, the hypothesis of convergent 
evolution could not be tested. 
 Once Nanopore sequencing was completed for the unevolved inoculum using the 
MinION device, the data was processed for quality as this new technology can produce 
about 5% error. Therefore, only single nucleotide polymorphisms appearing in at least 
5% of the reads were considered “real” and rarer single nucleotide polymorphisms were 
considered error and were eliminated from the data set. The genomics of the inoculum 
virions and the resulting six passaged lineages were to then be compared using MEGA 
(Molecular Evolutionary Genetics Analysis) which would have produced phylogenetic 
trees based on each population of sequences. By comparison of the phylogenetic 
structure, this data interpretation would have identified if convergent evolution had 
occurred throughout the serial passage experiment. 
Data Analysis 
 Fitness data was analyzed using RStudio software. Poisson regression models and 
estimated marginal means were used to analyze any changes in fecundity and 
development for passages 1, 5, 10, and Emel infected with Maur-evolved DCV. The 
average relative number of eggs, pupae, and adults were plotted for both hosts. The 
relative information was completed by first calculating the average number of eggs for 
each Maur and Emel control. The relative number of eggs for each sample was calculated 
by dividing each sample by the average of their respective control group. This was done 
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to minimize variance in the data across all the passages and to better compare the two 
species as D. mauritiana is, on average, less fecund. The average of each lineage was 
then calculated resulting in the average for all controls in all passage to become 1. The 
same process of relative quantification was also performed for pupae and adults.  
Survival analysis from the LT50 data was performed in RStudio with a right-
censored Kaplan-Meier estimates of survival curves. The associations of the survival 
times were additionally analyzed using the Cox proportional-hazards model.  
In the analysis of the RT-qPCR data, the amount of viral genomic RNA was 
quantified relative to the amount of reference gene (RpL32). The amplification 
efficiencies of each primer set were first calculated by using a 10-fold serial dilution of 
the cDNA from a fly previously injected with DCV and collected at the LT50. Each 10-
fold dilution was completed in triplicate and the Ct values determined for each. The slope 
of the Ct values was calculated in excel and added to the equation E = 10-1/slope. The 
amplification efficiency was then changed to a percentage. The Pfaffl method was used to 
calculate the relative quantification of virions for each sample. The formula used for 
relative quantification was:
 
(PFAFFL 2004). Within the calculation ∆Ct(target) = Ct(DCV primer in calibrator) – Ct 
(DCV primer in test) and ∆Ct(reference) = Ct(reference gene in calibrator) – Ct(reference 
gene in tests). The Etarget and Ereference were the amplification efficiencies previously found 
for each primer set during the 10-fold dilution series. The relative quantifications were 
then analyzed in RStudio using the analysis of variance (ANOVA) method. 
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 Primary Nanopore sequence data was acquired using MinKNOW. The taxonomy 
of each MinKNOW read from the unevolved virus was assigned using the EPI2ME 
workflow FASTQ What’s In My Pot (WIMP) (nanoporetech.com). The files were later 
re-base-called using the data processing toolkit Guppy v3.2.2 due to its recently increased 
accuracy potential (WICK et al. 2019). Minibar demultiplexer was then used to separate 
the lineages of the unevolved inoculum into individual folders based on their custom 
barcodes. Completing Minibar with the unevolved inoculum provided a comparison of 
the efficiency between each primer set. If the number of reads did not match between 
each barcode for the unevolved data, an unequal primer efficiency is indicated which 
would need to be fixed before completing the evolved analysis.  
RESULTS 
 Measures for fecundity were collected and analyzed as a proxy for virulence. The 
data included the total eggs, total pupae, total males, total females, and total adults within 
each vial at passages 1, 5, and 10. The number of eggs decreased significantly for each 
viral lineage of Maur and Emel from passage 1 to 5 (P < 0.001; Figure 4a). The number 
of eggs were indistinguishable between passage 5 and 10 (P > 0.05; Figure 4a). There 
were significantly fewer eggs in the DCV-infected Emel lineages versus Emel controls (P 
< 0.001; Figure 4a). Maur females also produced significantly fewer eggs in the DCV-
infected lineages when compared to the Maur controls (P < 0.001; Figure 4a). Besides 
Maur A (which was excluded because the infected females failed to oviposited), there 
were no significant differences in oviposition rates between the DCV-infected lineages of 
Maur and Emel (P > 0.05; Figure 4a). Analysis of total pupae reflected the decrease in 
fecundity. All DCV-infected lineages experienced a significant decline in the number of 
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pupae produced from passage 1 to 5 similar to the decrease in the number of eggs 
observed for each Maur and Emel DCV-infected lineages (P < 0.001; Figure 4b). The 
total number of pupae was indistinguishable from SP5 to SP10 (P > 0.05; Figure 4b). The 
exception was lineage Maur A which had significantly more pupae than Maur C in 
passage 1, but still significantly fewer than the Maur control (P < 0.001; Figure 4b).  
 The number of male and female offspring were counted 21 days after injection 
with DCV or the Schneider’s medium control. Schneider’s-injected control flies had 
significantly more male offspring (P < 0.001; Figure 4c). Except for the removed Maur A 
in passage 5, there was no strong species effect for male offspring number (P > 0.05; 
Figure 4c). At passage 1, there were no differences in the number of males between 
lineages of DCV-infected Emel, but there were significantly more males in Maur A than 
Maur C (P = 0.025). The total number of males decreased for all DCV-infected lineages 
of Maur from passage 1 to 5 (P < 0.001; Figure 4c). The number of males in DCV-
infected Emel A, B, and C also significantly decreased from passage 1 to 5 (P < 0.001; 
Figure 4c). The number of males decreased significantly in DCV-infected lineages for all 
but Emel A from passage 1 to 10 (P < 0.001; Figure 4c). The total number of females 
decreased for all DCV-infected lineages but Emel B from passage 1 to 5 (P < 0.001; 
Figure 4c). Similar to the male data, the number of females declined for all DCV-infected 
lineages of Maur and Emel from passage 1 to 10 (P < 0.002; Figure 4c). The total number 
of females was indistinguishable between species for DCV-infected lineages at each 
passage (P > 0.05; Figure 4c). 
 Lastly we examined the total number of adults in the initial vials after injection 
(non-green A vials) counted on day 21. A sharp decline in adults was observed from 
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passage 1 to 5 for each lineage of DCV-infected Maur and Emel (P < 0.001; Figure 4d). 
The number of adults from passage 5 to 10 also significantly decreased from passage 5 to 
10 for all lineages, except Maur C (P < 0.007; Figure 4d). The number of adults in Maur 
C was indistinguishable between passage 5 and 10 (P = 0.8980; Figure 4d). Each control 
contained more adults after 21 days than each of the DCV-infected treatments at each 
passage (P < 0.001; Figure 4d).  
Developmental timing was examined at passages 1, 5, and 10. The days to form 
the first pupa and the days to first adult emergence were determined for each vial of 
injected and control flies. There were no significant differences in developmental timing 
across species or treatments (P > 0.05; Figure 5).  
 Fly mortality was used as an additional proxy for virulence. Mortality was 
recorded daily for each lineage until half of all flies were dead in each lineage (LT50) or 
until 10 days post injection passed. The survival analysis showed no differences in the 
LT50 for any DCV-infected lineages from passage 1 to 10 (P > 0.05; Figure 6). An 
additional analysis using the Cox proportional-hazards model suggested a significantly 
higher probability of dying if flies were in the DCV-infected Maur lineages compared to 
Emel lineages and the control groups (P < 0.001; Figure 7; Figure 8). Conversely, 
Drosophila injected with Schneider’s medium had a greater probability of surviving (P < 
0.001; Figure 7; Figure 8).  
 Emel infected with Maur-evolved DCV was utilized to test whether the Maur-
evolved DCV (collected at the LT50 of passage 10) was less able to infect the native 
host. The Maur-evolved virus was injected into the naïve native host Emel and compared 
to Emel passage 1. The same measures for fecundity and development as passage 1 were 
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determined (total eggs, total pupae, total males, total females, total adults, days to pupae, 
and days to adult). As expected, the flies injected with Maur-evolved DCV laid 
significantly fewer eggs than the Schneider’s-injected controls (P < 0.001; Figure 9a). No 
distinguishable difference between Maur-evolved DCV-infected lineages were noted (P > 
0.05; Figure 9a). The flies injected with Maur-evolved DCV produced significantly fewer 
eggs than the flies injected with ancestral DCV (P < 0.001; Figure 9a). Concomitantly, 
there were significantly higher numbers of total pupae, total males, total females, and 
total adults in Emel SP1 compared to Maur-evolved infected Emel (P < 0.001; Figure 9b; 
Figure 9c; Figure 9d). The number of days to pupae formation or days to adult emergence 
were indistinguishable between Emel SP1 and the Emel infected with Maur-evolved 
inoculum (P > 0.05; Figure 10). 
 The final analysis for the Maur-evolved infected Emel was survival using the day 
each fly died until the LT50 was reached or 10 days post injection. No significant 
changes were noted from the ancestral injected Emel at passage 1 to the Maur-evolved 
infected Emel (P > 0.05; Figure 11).  
The 10-fold dilution series for the qPCR primers indicated the amplification 
efficiency for each primer set fell between 90-110% and were deemed optimal; however, 
there was an 8% difference between the amplification efficiency of the DCV primers and 
RpL32 gene primers. The Pfaffl method to calculate the virion load was chosen to 
accommodate the 8% amplification efficiency difference. A three-way ANOVA between 
passages, species, and lineages was completed in RStudio to analyze the qPCR data. 
Although several infected Maur flies had very high titer loads when compared to infected 
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Emel, there were no significant differences in the viral load among flies from passages 1 
to 5, 5 to 10, or 1 to 10 for any of the DCV-infected lineages (P > 0.05; Figure 12).    
A total of 22.52K unique sequences and 34.85 megabases were read by 
MinKNOW from the Nanopore sequencing run using the unevolved inoculum viral RNA. 
The estimated N50, the length of the shortest contig at 50% of the total genome length, 
was 3.55Kb. EPI2ME analyzed 11,981 reads with 10,882 of those classified into one 
taxon. A high percentage (95%) were classified as a virus totaling 10,354 of the 10,882 
classified reads within the Cripavirus genus, of which DCV is a member (Figure 13).  
The custom barcodes within the SSP and VNP primers were tested using the 
unevolved inoculum RNA in Nanopore sequencing. The number of reads was lower than 
expected. Just under 11,000 reads were successfully sequenced. Of those, 95% were 
DCV. The remaining reads appear to be some form of contamination. Demultiplexing of 
the barcodes was successful using Minibar indicating that our method of putting the 
barcodes into the strand switching primers is a viable methodology. However, the number 
of sequences within each barcode group was unbalanced (Table 2). Three of the barcodes 
contained enough reads to move to the next step of variant calling, but the other three had 
too low of coverage to enable the variant calling process. There were reads that only 
contained a barcode on either the 5’ or the 3’ end instead of at both ends, as was 
expected. More specifically, many of the reads appear to begin or end at the unique DCV 
sequence suggesting the VNP primer worked. The SSP primer appears to have bound 






Serial passaging experiments have been utilized for the study of host shifts but 
these are usually done with bacterial hosts and low virulence phage pathogens (BULL 
1994; EBERT 1998). Using Drosophila in SPE experiments should give a more accurate 
representation as to how a complex host will respond to a host shift (GALIANA-ARNOUX 
et al. 2006b; BRUSINI et al. 2013). It can also illustrate that complex hosts will not always 
react as predicted by standard SPE experiments (BRUSINI et al. 2013). Using DCV, a 
highly virulent pathogen, provides insight into how such a pathogen might behave after a 
host shift. 
The fecundity analysis demonstrated that DCV infection caused a sudden and 
sharp decrease in the number of eggs oviposited, the number of pupae formed, and the 
number of emerging adults for both the native and the novel host. This result suggests 
that the virus is equally virulent on the native and novel hosts. The decreased fecundity in 
both the native and novel host could be explained by the initiation of the innate immune 
response. While Drosophila have some means to fight a DCV infection, the use of the 
immune response may come as a cost to fitness (MCKEAN et al. 2008). Previous host 
shift experiments using DCV and Drosophila have demonstrated similar decreases in 
fitness for Drosophila melanogaster. The study by E. Hendrix in 2018 described 
metabolomic differences between the native and novel host which suggested the native 
host was better suited to regulate the DCV infection (LONGDON et al. 2015; HENDRIX 
2018). Based on this information, we would have expected a larger decrease in fecundity 
of DCV-infected D. mauritiana at SP1 in comparison to the native host. The differences 
in virulence between Hendrix and the current study might be due to differences in 
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virulence of the original inoculum. Although the inocula were sourced from the same lab, 
they were produced in different batches several years apart. 
The virus significantly increased in virulence early within the passaging 
experiment for both hosts. Also, while both hosts experienced a decrease in fecundity, the 
survivability analysis suggested the native host was still better suited to handle the DCV 
infection. This is in agreement with the findings from Hendrix 2018 (HENDRIX 2018). 
The flies within the control treatments lived longer than both Maur and Emel, but Maur 
lineages reached their LT50 points significantly sooner than Emel at each passage. The 
longer survivability times of Emel could be explained by the coevolution that has 
occurred between DCV and Emel. For this reason, the native host may be better equipped 
to recognize infection and adjust to survive longer than the novel host (LONGDON et al. 
2015; HENDRIX 2018). Previous studies with D. melanogaster and D. mauritiana support 
this finding. A previous host shift experiment suggested the two species of Drosophila 
regulate their metabolites differently with the novel host less able to cope with the DCV 
infection (HENDRIX 2018). The DCV virulence increase in the novel host supports the 
bacterial SPE hypothesis, but the significant increase in the native host was not expected 
since DCV is found to infect D. melanogaster in nature (EBERT 1998; LONGDON et al. 
2015). The high starting virulence of DCV on the native host could explain this result 
(JOUSSET et al. 1977). The majority of previous host shift experiments have been 
performed using pathogens that naturally have low native host virulence (BULL 1994). 
Additionally, the decrease in fecundity but unchanged survival times could indicate a 
balance between reproduction and survivability occurring within the native host. This 
could again be a coping mechanism by Drosophila to reallocate energy for immune 
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response assistance found in other Drosophila studies (MORET and SCHMID-HEMPEL 
2000; LONGDON et al. 2015; HENDRIX 2018). 
The transmission mode could also be influencing these results. Pathogens 
utilizing vertical transmission alone favor a decrease in virulence over time. Contrary to 
this, pathogens that normally cause minor harm to the host have shown sudden increases 
in virulence after only a few horizontal passages (ANTONOVICS et al. 2017; LE CLEC'H et 
al. 2017). While vertical transmission relies on the host’s offspring to survive, 
horizontally-transmitted pathogens may have the ability to evolve quickly without the 
need for host offspring (ANTONOVICS et al. 2017). For our study, utilizing artificial 
injection resulted in guaranteed horizontal transmission. This could have caused a 
selective advantage for the more virulent strains of DCV without the limiting step of 
requiring the host to survive long enough to complete successful transmission to the next 
host (LIPSITCH et al. 1995; ANTONOVICS et al. 2017). To mitigate the experimenter’s 
influence on the artificial injecting process, the viral dose from one passage to the next 
was not controlled allowing the virion load to change naturally.  
The decreases in fecundity for each lineage of Maur and Emel from passage 1 to 
10 indicates the virulence of DCV increased on both the native and novel host. However, 
the viral titers did not change significantly to explain the increase in virulence. The 
pathogen appeared to increase in virulence without needing to produce a higher number 
of virions. Other serial passaging studies completed with Drosophila and the vertically 
transmitted Sigma virus have suggested opposite effects (LONGDON et al. 2011a). A study 
performed by Londgon et al. 2015 showed an increase in viral load that correlated with 
increases in virulence. The viral titer had an even more prominent increase between 
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species of Drosophila that were closely related such as D. melanogaster and D. 
mauritiana (LONGDON et al. 2015). Based on these studies, and a number of others that 
have also found high viral titers that parallel increased virulence, we would have 
expected to see an increasing DCV viral load within this experiment (BRUSINI et al. 2013; 
LONGDON et al. 2015). The major difference here is that DCV is a highly virulent 
horizontally transmitted pathogen as opposed to the pathogen used in these previous 
studies (Sigma rhabdovirus) which is a vertically transmitted pathogen with minimal 
virulence. Thus the mechanism by which DCV’s virulence increased remains unclear.  
The virus evolved on the novel host was more virulent to naïve native hosts 
(Emel) than the ancestral virus. Testing the hypothesis that the novel evolved virus would 
be less virulent on the native host was not supported based on the observed decrease in 
fecundity. The naïve native hosts produced significantly fewer eggs, pupae, and adults 
when injected with the Maur-evolved virus in comparison to injection with the original 
DCV inoculum. Other host shift studies have found a decrease in the ability of the 
pathogen to infect the native host once it is better suited to infect the novel host (EBERT 
1998). This contrasts with our results. The species Maur and Emel are closely related so 
they could share similar pathways which allowed DCV to evolve within Maur while 
remaining equally able to infect and kill Emel using similar mechanisms (CLARK et al. 
2007; CHANG et al. 2016). Additionally, DCV is highly virulent to its native host and it’s 
possible that after many more passages the virus would have become less virulent on the 
native host. 
Testing of convergent evolution could not be completed due to disruptions caused 
by COVID-19. This could have helped to explain whether the Maur-evolved DCV 
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experienced paralleled changes within each lineage suggesting a specific variant that was 
best able to survive in the new host environment (DOMINGO and HOLLAND 1997). 
Previous studies have shown specific genotypes become more prominent each time a 
shift from the native to novel host occurs and contribute positively to how the pathogen 
performs on the novel host (VERTACNIK and LINNEN 2017; LONGDON et al. 2018). The 
differing unevolved barcoding results could have occurred due to sample fragmentation 
during the sample preparation process. The VNP primers appear to successfully bind to 
the complimentary unique DCV sequence within the virions but many of the SSP primers 
bound nonspecifically to internal portions of DCV. Thus, in future experiments new SSP 
primers need to be designed and/or the priming conditions need to be optimized. It is 
difficult to discern the source of the variance in the number of each barcode present in the 
read pool, given the overall low number of reads. It is likely that the low number of reads 
can be ameliorated by improving the design of the sequence-specific region of the SSP 
primer. 
Disease emergence in novel hosts are often associated with a pathogen’s ability to 
adapt to said host. Understanding these mechanisms can have important implications to 
predicting or even preventing outbreaks (DOWLING et al. 2020). Many of these host shift 
findings have been done using bacteria and with low virulence pathogens in SPEs. Our 
study compared those findings to a more complex host, Drosophila, and a highly virulent 
pathogen. Similar to bacterial SPEs, the pathogen did increase in virulence on the novel 
host following the host shift even though the virus was already highly virulent to the 
native host (BULL 1994; EBERT 1998). However, the evolved virus was still able to 
significantly decrease the fecundity of the native host, not matching bacterial SPE 
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predictions. This suggests some of these bacterial hypotheses may still hold with complex 
organisms and with high virulence pathogens. These findings could benefit from 
additional metabolomic and proteomic analysis along with immune markers via RT-
qPCR. Such work would aide in further elucidation of the host species’ responses in 
reaction to changes in virulence by the virus. Our results highlight the importance of 
performing SPEs using more complex host organisms and pathogens with varying 
degrees of virulence on the native host so that we can continue improving our 
understanding of pathogen virulence following a host shift.  
At present, the human population is experiencing a host-shift event with SARS-
CoV-2 the likes of which has not been seen in the human population in a very long time. 
This event clearly illustrates the need for continued study of host shifts and virulence 
evolution following such that we may eventually be able to predict and possibly prevent 




Adams, M. D., S. E. Celniker, R. A. Holt, C. A. Evans, J. D. Gocayne et al., 2000 The 
genome sequence of Drosophila melanogaster. Science: 2185-2195. 
Ahmed, A. M., S. L. Baggott, R. Maingon and H. Hurd, 2002 The costs of mounting an 
immune response are reflected in the reproductive fitness of the mosquito 
Anopheles gambiae. Oikos: 371-377. 
Alizon, S., A. Hurford, N. Mideo and M. Van Baalen, 2009 Virulence evolution and the 
trade-off hypothesis: history, current state of affairs and the future. J. Evol. Biol. : 
245-259. 
Antonovics, J., A. J. Wilson, M. R. Forbes, H. C. Hauffe, E. R. Kallio et al., 2017 The 
evolution of transmission mode. Philos. Trans. R. Soc. Lond., B, Biol. Sci.: 12. 
Best, A., A. White and M. Boots, 2014 The coevolutionary implications of host tolerance. 
Evolution: 1426-1435. 
Betts, A., C. Gray, M. Zelek, R. C. MacLean and K. C. King, 2018 High parasite 
diversity accelerates host adaptation and diversification. Science: 907-+. 
Bier, E., M. M. Harrison, K. M. O'Connor-Giles and J. Wildonger, 2018 Advances in 
engineering the fly genome with the CRISPR-Cas system. Genetics: 1-18. 
Bonneaud, C., M. Giraudeau, L. Tardy, M. Staley, G. E. Hill et al., 2018 Rapid 
antagonistic coevolution in an emerging pathogen and its vertebrate host. Curr. 
Biol: 2978-+. 
Brusini, J., Y. Wang, L. Matos, L. Sylvestre, B. Bolker et al., 2013 Virulence evolution 
in a host-parasite system in the absence of viral evolution. Evol. Ecol. Res.: 883-
901. 
Bull, J., 1994 Perspective: virulence. Evolution: 1423-1437. 
Chang, T. C., A. Salvucci, P. W. Crous and I. Stergiopoulos, 2016 Comparative 
genomics of the Sigatoka disease complex on banana suggests a link between 
parallel evolutionary changes in Pseudocercospora fijiensis and 
Pseudocercospora eumusae and increased virulence on the banana host. Plos 
Genet.: 35. 
Cherry, S., and N. Perrimon, 2004 Entry is a rate-limiting step for viral infection in a 
Drosophila melanogaster model of pathogenesis. Nat. Immunol.: 81-87. 
Chintapalli, V. R., J. Wang and J. A. T. Dow, 2007 Using FlyAtlas to identify better 
Drosophila melanogaster models of human disease. Nat. Genet.: 715-720. 
Clark, A. G., M. B. Eisen, D. R. Smith, C. M. Bergman, B. Oliver et al., 2007 Evolution 
of genes and genomes on the Drosophila phylogeny. Nature: 203-218. 
Cleaveland, S., M. K. Laurenson and L. H. Taylor, 2001 Diseases of humans and their 
domestic mammals: pathogen characteristics, host range and the risk of 
emergence. Philos. Trans. R. Soc. Lond. Ser. B-Biol. Sci.: 991-999. 
43 
 
Coronaviridae Study, G., 2020 The species Severe acute respiratory syndrome-related 
coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature 
Microbiology 5: 536-544. 
Dennehy, J. J., N. A. Friedenberg, R. D. Holt and P. E. Turner, 2006 Viral ecology and 
the maintenance of novel host use. Am. Nat.: 429-439. 
Desjardins, C. A., C. Giamberardino, S. M. Sykes, C. H. Yu, J. L. Tenor et al., 2017 
Population genomics and the evolution of virulence in the fungal pathogen 
Cryptococcus neoformans. Genome Res.: 1207-1219. 
Domingo, E., and J. J. Holland, 1997 RNA virus mutations and fitness for survival. 
Annu. Rev. Microbiol.: 151-178. 
Dowling, A., G. Hill and C. Bonneaud, 2020 Multiple differences in pathogen-host cell 
interactions following a bacterial host shift. Scientific Reports 10. 
Drake, J. W., and J. J. Holland, 1999 Mutation rates among RNA viruses. Proc. Natl. 
Acad. Sci. U.S.A.: 13910-13913. 
Duffy, S., L. A. Shackelton and E. C. Holmes, 2008 Rates of evolutionary change in 
viruses: patterns and determinants. Nat. Rev. Genet.: 267-276. 
Duneau, D., J. B. Ferdy, J. Revah, H. Kondolf, G. A. Ortiz et al., 2017 Stochastic 
variation in the initial phase of bacterial infection predicts the probability of 
survival in D. melanogaster. Elife: 23. 
Ebert, D., 1998 Evolution - experimental evolution of parasites. Science: 1432-1435. 
Ellison, A. R., G. V. DiRenzo, C. A. McDonald, K. R. Lips and K. R. Zamudio, 2017 
First in vivo Batrachochytrium dendrobatidis transcriptomes reveal mechanisms 
of host exploitation, host-specific gene expression, and expressed genotype shifts. 
G3-Genes Genomes Genet.: 269-278. 
Ewald, P. W., 1983 Host-parasite relations, vectors, and the evolution of disease severity. 
Annu. Rev. Ecol. Evol. Syst.: 465-485. 
Frank, S., 1996 Models of parasite virulence. Q. Rev. Biol.: 37-78. 
Galiana-Arnoux, D., C. Dostert, A. Schneemann, J. A. Hoffmann and J. L. Imler, 2006a 
Essential function in vivo for Dicer-2 in host defense against RNA viruses in 
drosophila. Nature Immunology 7: 590-597. 
Galiana-Arnoux, D., C. Dostert, A. Schneemann, J. A. Hoffmann and J. L. Imler, 2006b 
Essential function in vivo for Dicer-2 in host defense against RNA viruses in 
Drosophila. Nat. Immunol.: 590-597. 
Giot, L., J. S. Bader, C. Brouwer, A. Chaudhuri, B. Kuang et al., 2003 A protein 
interaction map of Drosophila melanogaster. Science: 1727-1736. 
Gomez, P., B. Ashby and A. Buckling, 2015 Population mixing promotes arms race host-
parasite coevolution. Proc. R. Soc. B-Biol. Sci.: 8. 
Group, C. S., 2020 The species Severe acute respiratory syndrome-related coronavirus: 




Hendrix, E. K., 2018 Characterizing the early stages of a novel host shift using host 
fitness and metabolomics, pp., EWU Masters Thesis Collection. 
Hoberg, E. P., and D. R. Brooks, 2015 Evolution in action: climate change, biodiversity 
dynamics and emerging infectious disease. Philos. Trans. R. Soc. B-Biol. Sci.: 7. 
Howard, C. R., and N. F. Fletcher, 2012 Emerging virus diseases: can we ever expect the 
unexpected? Emerg. Microbes Infect.: 11. 
Jansen, G., L. L. Crummenerl, F. Gilbert, T. Mohr, R. Pfefferkorn et al., 2015 
Evolutionary transition from pathogenicity to commensalism: global regulator 
mutations mediate fitness gains through virulence attenuation. Mol. Biol. Evol.: 
2883-2896. 
Jousset, F., M. Bergoin and B. Revet, 1977 Characterization of the Drosophila C virus. J. 
Gen. Virol.: 269-285. 
Le Clec'h, W., J. Dittmer, M. Raimond, D. Bouchon and M. Sicard, 2017 Phenotypic 
shift in Wolbachia virulence towards its native host across serial horizontal 
passages. Proc. R. Soc. B-Biol. Sci.: 10. 
Levin, B., 1996 The evolution and maintenance of virulence in microparasites. Emerg. 
Infect. Dis.: 93-102. 
Licht, H. H. D., 2018 Does pathogen plasticity facilitate host shifts? Plos Pathog.: 9. 
Linde, J., S. Duggan, M. Weber, F. Horn, P. Sieber et al., 2015 Defining the 
transcriptomic landscape of Candida glabrata by RNA-Seq. Nucleic Acids Res.: 
1392-1406. 
Lipsitch, M., M. A. Nowak, D. Ebert and R. M. May, 1995 The population dynamics of 
vertically and horizontally transmitted parasites. Proc. R. Soc. B-Biol. Sci.: 321-
327. 
Lipsitch, M., S. Siller and M. A. Nowak, 1996 The evolution of virulence in pathogens 
with vertical and horizontal transmission. Evolution: 1729-1741. 
Little, T. J., K. Watt and D. Ebert, 2006 Parasite-host specificity: experimental studies on 
the basis of parasite adaptation. Evolution: 31-38. 
Longdon, B., J. P. Day, J. M. Alves, S. C. L. Smith, T. M. Houslay et al., 2018 Host 
shifts result in parallel genetic changes when viruses evolve in closely related 
species. Plos Pathog.: 14. 
Longdon, B., J. D. Hadfield, J. P. Day, S. C. L. Smith, J. E. McGonigle et al., 2015 The 
causes and consequences of changes in virulence following pathogen host shifts. 
Plos Pathog.: 18. 
Longdon, B., J. D. Hadfield, C. L. Webster, D. J. Obbard and F. M. Jiggins, 2011a Host 
phylogeny determines viral persistence and replication in novel hosts. Plos 
Pathog.: 9. 
Longdon, B., L. Wilfert, J. Osei-Poku, H. Cagney, D. J. Obbard et al., 2011b Host-




Lubinski, J., L. Y. Wang, D. Mastellos, A. Sahu, J. D. Lambris et al., 1999 In vivo role of 
complement-interacting domains of herpes simplex virus type 1 glycoprotein gC. 
Journal of Experimental Medicine 190: 1637-1646. 
Mackinnon, M. J., and A. F. Read, 2004 Immunity promotes virulence evolution in a 
malaria model. Plos Biol.: 1286-1292. 
May, R. M., and R. M. Anderson, 1983 Epidemiology and genetics in the coevolution of 
parasites and hosts. Proc. R. Soc. B-Biol. Sci.: 281-313. 
McKean, K. A., C. P. Yourth, B. P. Lazzaro and A. G. Clark, 2008 The evolutionary 
costs of immunological maintenance and deployment. Bmc Evolutionary Biology 
8. 
Monsanto-Hearne, V., and K. N. Johnson, 2018 Wolbachia-mediated protection of 
Drosophila melanogaster against systemic infection with its natural viral pathogen 
Drosophila C virus does not involve changes in levels of highly abundant 
miRNAs. Journal of General Virology 99: 827-831. 
Moret, Y., and P. Schmid-Hempel, 2000 Survival for immunity: The price of immune 
system activation for bumblebee workers. Science 290: 1166-1168. 
Morley, V. J., S. Y. Mendiola and P. E. Turner, 2015 Rate of novel host invasion affects 
adaptability of evolving RNA virus lineages. Proc. R. Soc. B-Biol. Sci.: 7. 
Nam, J. H., S. M. Shim, E. J. Song, E. Espano, D. G. Jeong et al., 2017 Rapid virulence 
shift of an H5N2 avian influenza virus during a single passage in mice. Arch. 
Virol.: 3017-3024. 
Osborne, S. E., Y. S. Leong, S. L. O'Neill and K. N. Johnson, 2009 Variation in antiviral 
protection mediated by different Wolbachia strains in Drosophila simulans. Plos 
Pathog.: 9. 
Parker, I. M., and G. S. Gilbert, 2004 The evolutionary ecology of novel plant-pathogen 
interactions. Annu. Rev. Ecol. Evol. Syst.: 675-700. 
Patz, J. A., T. K. Graczyk, N. Geller and A. Y. Vittor, 2000 Effects of environmental 
change on emerging parasitic diseases. Int. J. Parasitol: 1395-1405. 
Pfaffl, M. W., 2004 Quantification strategies in real-time PCR, pp. 87-112 in A-Z of 
quantitative PCR, edited by S. A. Bustin. International University Line. 
Ponton, F., M. P. Chapuis, M. Pernice, G. A. Sword and S. J. Simpson, 2011 Evaluation 
of potential reference genes for reverse transcription-qPCR studies of 
physiological responses in Drosophila melanogaster. J. Insect Physiol.: 840-850. 
Regoes, R. R., M. A. Nowak and S. Bonhoeffer, 2000 Evolution of virulence in a 
heterogeneous host population. Evolution: 64-71. 
Rogalski, M. A., C. D. Gowler, C. L. Shaw, R. A. Hufbauer and M. A. Duffy, 2017 
Human drivers of ecological and evolutionary dynamics in emerging and 
disappearing infectious disease systems. Philosophical Transactions of the Royal 
Society B-Biological Sciences 372: 9. 
46 
 
Sabatier, L., E. Jouanguy, C. Dostert, D. Zachary, J. L. Dimarcq et al., 2003 Pherokine -2 
and -3: two Drosophila molecules related to pheromone/odor-binding proteins 
induced by viral and bacterial infections. Eur. J. Biochem.: 3398-3407. 
Sharp, P. M., and B. H. Hahn, 2011 Origins of HIV and the AIDS Pandemic. Cold Spring 
Harbor Perspectives in Medicine 1: 22. 
Shin, J., and T. MacCarthy, 2016 Potential for evolution of complex defense strategies in 
a multi-scale model of virus-host coevolution. BMC Evol. Biol.: 15. 
Silva, W. M., F. A. Dorella, S. C. Soares, G. Souza, T. L. P. Castro et al., 2017 A shift in 
the virulence potential of Corynebacterium pseudotuberculosis biovar ovis after 
passage in a murine host demonstrated through comparative proteomics. BMC 
Microbiol.: 14. 
van den Bosch, F., B. A. Fraaije, F. van den Berg and M. W. Shaw, 2010 Evolutionary 
bi-stability in pathogen transmission mode. Proc. R. Soc. B-Biol. Sci.: 1735-1742. 
van Sluijs, L., G. P. Pijlman and J. E. Kammenga, 2017 Why do individuals differ in viral 
susceptibility? a story told by model organisms. Viruses-Basel: 13. 
VanGuilder, H. D., K. E. Vrana and W. M. Freeman, 2008 Twenty-five years of 
quantitative PCR for gene expression analysis. Biotechniques: 619-626. 
Vertacnik, K. L., and C. R. Linnen, 2017 Evolutionary genetics of host shifts in 
herbivorous insects: insights from the age of genomics. Ann. N.Y. Acad. Sci.: 
186-212. 
Watanabe, S., J. S. Masangkay, N. Nagata, S. Morikawa, T. Mizutani et al., 2010 Bat 
Coronaviruses and Experimental Infection of Bats, the Philippines. Emerging 
Infectious Diseases 16: 1217-1223. 
Wick, R. R., L. M. Judd and K. E. Holt, 2019 Performance of neural network basecalling 
tools for Oxford Nanopore sequencing. Genome Biology 20: 129. 
Woolhouse, M. E. J., and S. Gowtage-Sequeria, 2005 Host range and emerging and 





Table 1: The custom primers used for the Nanopore direct cDNA protocol during 
Nanopore sequencing. Each VPN primer included a unique DCV sequence along with the 
VPN sequence found on the Nanopore website and a custom barcode. The SSP primers 
included the SSP sequence recommended by Nanopore along with a custom barcode for 
each lineage. 
Primer Primer Sequence 5'-3' Barcode 
VPN-Maur A ACTTGCCTGTCGCTCTATCTTCCAACTTTCTTCATCGAATTGCCAAAACCGC CAACTTTCTT 
VPN-Maur B ACTTGCCTGTCGCTCTATCTTCAACCAAGACTCATCGAATTGCCAAAACCGC AACCAAGACT 
VPN-Maur C ACTTGCCTGTCGCTCTATCTTCGAGAGGACAACATCGAATTGCCAAAACCGC GAGAGGACAA 
VPN-Emel A ACTTGCCTGTCGCTCTATCTTCGTTCCCTGAACATCGAATTGCCAAAACCGC GTTCCCTGAA 
VPN-Emel B ACTTGCCTGTCGCTCTATCTTCAAAGGTTTCACATCGAATTGCCAAAACCGC AAAGGTTTCA 
VPN-Emel C ACTTGCCTGTCGCTCTATCTTCGGTTTGTTCCCATCGAATTGCCAAAACCGC GGTTTGTTCC 
SSP-Maur A TTTCTGTTGGTGCTGATATTGCTCAACTTTCTTmGmGmG CAACTTTCTT 
SSP-Maur B TTTCTGTTGGTGCTGATATTGCTAACCAAGACTmGmGmG AACCAAGACT 
SSP-Maur C TTTCTGTTGGTGCTGATATTGCTGAGAGGACAAmGmGmG GAGAGGACAA 
SSP-Emel A TTTCTGTTGGTGCTGATATTGCTGTTCCCTGAAmGmGmG GTTCCCTGAA 
SSP-Emel B TTTCTGTTGGTGCTGATATTGCTAAAGGTTTCAmGmGmG AAAGGTTTCA 





Table 2: The number of reads per barcode was very uneven in the data. Using Minibar, 
the total number of reads identified by Minibar with their designated custom barcodes on 
both the 5’ and 3’ ends are listed in the first second column of the table. There were also 
reads that contained a barcode on either the 5’ or 3’ end rather than both. Two barcodes 
were present on a higher number of total reads when compared to the other barcodes.  
Barcode Total reads: both 5' and 3' 
barcodes present 
Total reads: 5' or 3' 
barcode 
GTTCCCTGAA 6 4 
AAAGGTTTCA 8 7 
GGTTTGTTCC 2 1 
CAACTTTCTT 0 0 
AACCAAGACT 63 21 






Figure 1. Serial passage experiment setup schematic. The passage process started by 
injecting naïve native and novel hosts with DCV inoculum generated in cell culture. A 
unique evolved DCV inoculum was then used for each lineage after passage 1. The 
inoculum was obtained by homogenizing 10 of the surviving native or novel hosts 
collected at the LT50 or day 10 for each viral lineage. For example, the homogenate from 
passage 1 Emel A was injected into naïve Emel A to start 2. This process was repeated 
for each viral lineage until 10 serial passages were completed. Each of the 3 viral lineages 















Figure 2. Analysis setup during serial passage experimentation. DCV inocula were 
generated from the native and novel host at the LT50 point and injected into a new set of 
naïve hosts. The viral titer at the LT50 point was measured using RT-qPCR at serial 
passages 1, 5, and 10. The host fitness was analyzed at serial passages 1, 5, and 10 using 
fly fecundity and development as proxies for virulence. Nanopore sequencing was 
completed on the ancestral DCV before serial passaging. Because of disruptions due to 
COVID-19 the evolved virus was not sequenced, and the hypothesis of convergent 





Figure 3: General schematic for the fitness analyses setup performed at passages 1, 5, 10, 
and Maur-evolved infected Emel. Immediately after injection with DCV or control 
media, each fly was placed in an individual vial (A) and a non-injected male was added. 
After 24hrs each set of flies was flipped to a new individual vial with green-tinted media 
(B), allowed to lay, and flipped back to the original vial (A) after 24 hours. The 
hatchability assay included counting the number of eggs oviposited after 24 hours on the 
green-tinted vial (B) then counting the number of unhatched eggs after 48 hours. The 
development assay included monitoring the number of days to first pupa formation and 
the days for the first adult to emerge in each vial (B). The total number of pupae were 
also counted after 10 days along with the number of females and males after 21 days in 
each vial (B). The total number of adults in each vial (A) were counted after 21 days.  
52 
 
Figure 4a-d: The number of eggs, pupae, and adults decreased for each lineage of Maur 
and Emel. The relative numbers for each measure of fecundity were calculated from the 
green tinted vials at SP1, 5, and 10. Both hosts showed significant decreases in eggs 
oviposited from SP1 to SP5 (P < 0.001; Figure 4a). The number of eggs between passage 
5 and 10 were indistinguishable for each lineage (P > 0.05; Figure 4a). The relative 
number of pupae and adults in the green-tinted vials (B) also experienced significant 
decreases in numbers from SP1 to SP5 (P < 0.001; Figure 4b; Figure 4c). There were 
similarly no significant changes in the number of pupae or adults from SP5 to SP10 (P > 
0.05; Figure 4b; Figure 4c). The relative number of adults was also measured from the 
initial tan vials (A) at SP1, 5, and 10 shown in Figure 4d. The fecundity of the two host 
species significantly decreased from SP1 to SP5 based on the number of adults (P < 
0.001; Figure 4d). All but Maur C also showed a significant decrease in adults from SP5 
to SP10 (P < 0.007; Figure 4d). Passage Maur C was indistinguishable between passage 5 
and 10 (P = 0.8980; Figure 4d). Each measure of fecundity showed significant declines 




Figure 5: No significant differences in days to adult were found for Maur or Emel 
between passages (P > 0.05). The times to adult were measured from the green tinted 
vials (B) at SP1, 5, and 10. Maur A SP5 has not been included because the infected 
females failed to oviposited. 
54 
 
Figure 6: The probability of surviving did not change from passage 1 to 10 (P > 0.05). A 
right-censored Kaplan-Meier estimate of survival curves was used to analyze the 
probability of survival for each lineage over the serial passaging experiment. No 
significant changes in survivability were discovered for any lineage (P > 0.05). This 
means, even though pathogen virulence increased the flies did not die significantly faster 
within their respective lineages. 
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Figure 7: DCV was significantly more virulent on the novel host Maur (P < 0.001). A 
right-censored Kaplan-Meier estimate of survival curves was used to analyze the 
probability of survival between each species and treatment (control vs DCV injection). 
Flies within the Maur lineages had a significantly higher probability of dying sooner than 
Emel lineages and the control treatments (P < 0.001). If the Drosophila were part of the 
control treatments for both species, they had a higher probability of surviving (P < 
0.001). There is a species and treatment effect on survivability. 
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Figure 8. Lineages of Maur had a higher probability of dying while the control treatment 
groups had a higher probability of surviving (P < 0.001). This graph represents the odds 
ratio of dying for each lineage and for the total flies within each passage. It uses the day 
each fly died until the LT50 point or 10 days was reached in order to calculate this ratio. 
The horizontal bars represent the 95% confidence intervals. These ratios are in 
comparison to Emel A. Anything in blue indicates a higher probability of dying while the 




Figure 9a-d. The decrease in fecundity suggests that the Maur-evolved DCV was more 
virulent on the native host than the ancestral DCV. The Maur-evolved DCV collected 
from passage 10 was injected into naïve native hosts, Emel, in order to test whether the 
novel evolved virus would be less virulent on the native host. The changes in fecundity 
relative to their respective controls are shown in Figures a-d. There were significantly 
fewer eggs counted in Emel infected with Maur-evol DCV when compared to Emel 
passage 1 (P < 0.001; Figure 9a). Significantly fewer pupae and total adults in both vials 
A and B (initial tan vials and green-tinted vials) were found in Maur-evol DCV infected 
Emel versus initial DCV inoculum Emel in passage 1 (P < 0.001; Figure 9b; Figure 9c; 
Figure 9d). The novel evolved virus appears to still be able to significantly decrease the 
fecundity of the native host.
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Figure 10. The days to adult emergence was not significantly different between Emel 
passage 1 and the Emel infected with Maur-evolved DCV (P > 0.05). The average days to 
adult for each DCV-infected lineage and control are represented in Figure 10. When the 
naïve native hosts were injected with the novel evolved virus, the development time in 
order to reach adults emergence did not appear to be affected. This suggests while the 
Maur-evolved DCV lowered the fecundity of Emel, the development times did not 
change.   
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Figure 11. The survivability of Emel flies infected with Maur-evolved inoculum was like 
Emel passage 1 (P > 0.05). A right-censored Kaplan-Meier estimate of survival curves 
was used to analyze the probability of survival for each lineage of Maur-evol infected 
Emel compared to Emel SP1. Injection of naïve native hosts with the Maur-evolved virus 
did not appear to shorten the survival time when compared to Emel infected with the 
initial DCV inoculum.  
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Figure 12. The relative quantification of DCV viral titer did not change from passage 1 to 
5 or from passage 5 to 10 (P > 0.05).There was also no significant difference in viral titer 
between the native and novel host (P > 0.05). The DCV viral load was measured for each 
sample relative to the housekeeping gene RpL32 during RT-qPCR. The fecundity of each 
lineage showed a significant decrease from passage 1 to 10, but the viral titer does not 




Figure 13. Analysis of nanopore sequencing indicated that our sequencing was successful 
as EPI2ME classified 95% of sequences as viral. More specifically 10,354 reads of the 
total 10,882 as belonging to the taxa Cripavirus. This matches the taxonomy of DCV and 




Appendix I: RNA isolation protocol with TRIzol® 
1. HOMOGENIZATION 
a. Chill fly and put it into a clean tube with 200µl of TRIzol® 
i. (for multiple flies add 100µl per extra fly up to 1ml; up to 50 flies 
can be done in 1 ml of TRIzol®.  If doing more than one fly, ramp 
all volumes accordingly (except for ethanol washes and final 
suspension, those stay constant) 
b. Homogenize on ice with Kontes homogenizers until only the wings and 
bits of exoskeleton are distinguishable 
c. Cap and vortex each tube on electric vortexer at max speed for 5 seconds 
[Shake by hand it you want long RNA (>2000bp) but yield will probably 
go down some] 
d. Incubate the homogenized samples for 5 minutes at room temp 
2. PHASE SEPARATION 
a. Add 40µl of chloroform for the first fly and 20µl more for each additional 
fly 
b. Cap sample tubes securely 
c. Vortex tubes for 5 seconds and incubate them at room temperature for 2 to 
3 minutes 
d. Centrifuge the sample at no more than 12,000 × g for 10 minutes at 2 to 
8°C 
i. Following centrifugation, the mixture separates into a lower red, 
phenol-chloroform phase, an interphase that has the protein 
precipitate, and a colorless upper aqueous phase. RNA remains 
exclusively in the aqueous phase. The volume of the aqueous 
phase is about 60% of the volume of TRIzol® Reagent used for 
homogenization. 
e. Transfer the aqueous phase to a fresh tube 
i. Do not contaminate the aqueous phase with any of the other 
phases. IF you do, you can centrifuge the samples again and try 
again.  
3. RNA PRECIPITATION 
a. Add 100µl of isopropyl alcohol (50µl more for each additional fly) to the 
aqueous phase and shake vigorously 
b. Incubate samples at -20ºC for 10 minutes 
c. Centrifuge at no more than 12,000 × g for 10 minutes at 2 to 8°C.  
i. This should produce a gel-like whitish pellet on the side and 
bottom of the tube 
ii. Remove supernatant and discard 
4. RNA WASH 
a. Add 1 ml of cold (-4ºC) 75% ethanol (this volume remains the same 
whether you do 1-10 flies) 
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b. Mix the sample by vortexing and centrifuge at no more than 7,500 × g for 
5 minutes at 2 to 8°C 
i. RNA can be left in alcohol at 4ºC for 1 week or longer at-20ºC 
c. Discard alcohol 
d. Quick spin the tubes and use a pipette to discard extra alcohol at bottom of 
tubes  
e. Air-dry the RNA pellet for 5 minutes 
5. REDISSOLVING THE RNA 
a. Dissolve RNA  
i. add 29µl of DEPC-treated RNase-free water  
ii. add 1µl of RNAse inhibitor and mix by flicking he tube for about 
10 seconds 
iii. Incubate for 10 minutes at 55°C 



































Appendix II: Reverse Transcription 
 
1. PRIMER PREPARATION 
a. Mix and centrifuge each component before use. Combine the following: 
i. 2µl Experimental RNA (at concentration of 200ng/µl) 
ii. 1µl Random Primer 
iii. 2µl Nuclease-Free Water 
b. Heat in a 70°C heat block for 5 minutes 
i. Chill immediately in ice water for 5 minutes 
ii. Centrifuge for 10 seconds in a microcentrifuge 
iii. Store on ice until reverse transcription is added 
2. REVERSE TRANSCRIPTION PREPARATION 
a. Prepare the reverse transcription reaction mix on ice in the order listed: 
i. 4µl GoScript™ 5X Reaction Buffer 
ii. 2µl MgCl2 (Concentration of 2mM) 
iii. 1µl PCR Nucleotide Mix (Concentration of 0.5mM each dNTP) 
iv. 0.5µl Recombinant RNasin® Ribonuclease Inhibitor (20 units) 
v. 0.1µl GoScript™ Reverse Transcriptase 
vi. 7.4µl Nuclease-Free Water 
b. Combine 15µl of reverse transcription mix with 5µl of RNA and primer 
mix 
3. ANNEAL AND EXTEND 
a. Anneal in a heat block at 25°C for 5 minutes 
b. Extend in a heat block at 42°C for 1 hour 
i. Reaction can be stopped and stored at 0-5°C for analysis of cDNA 
4. REVERSE TRANSCRIPTASE INACTIVATION 
a. Inactivate Reverse Transcriptase before proceeding with qPCR in heat 





















Appendix III: qPCR 
 
1. COMPONENT PREPARATION 
a. Combine the following for a 96-Well plate (15µl/well) 
i. 7.5µl SYBR® Select Master Mix for CFX (2X) 
ii. 1µl Forward Primer 
iii. 1µl Reverse Primer 
iv. 1µl cDNA Template 
v. 4.5µl RNase-Free Water 
b. Mix components thoroughly then centrifuge briefly to eliminate air 
bubbles 
2. PLATE PREPARATION 
a. Transfer 15µl of reaction mix to each well of an optical plate 
b. Seal the plate with an optical adhesive cover 
i. centrifuge the plate to spin down content and eliminate air bubbles 
c. qPCR can be performed on the reaction plate at any time up to 72 hours 
when kept at room temperature and protected from exposure to direct light 
3. QPCR SETTINGS 
a. Run the PCR Reaction Plate with a CFX real-time PCR system using 
settings of: 
i. 95°C for 2 minutes 
ii. 40 cycles of: 
1. 94°C for 10 seconds 
2. 55°C for 30 seconds 
3. 72°C for 30 seconds 























Appendix IV: Inoculum preparation for serial passage 2 through 11 
 
1. HOMOGENIZATION 
a. Add 10 flies to a clean 1.5ml tube 
i. Add 200µl of Schneider’s medium 
b. Homogenize on ice with Kontes homogenizers until only the wings and 
bits of exoskeleton are distinguishable 
c. Cap tubes and vortex for 5 seconds 
d. Centrifuge at 5°C for 5 minutes at 30,000 rcf 
2. SUPERNATANT COLLECTION 
a. Add supernatant to a fresh 1.5 ml tube 




































Appendix V: Nanopore Sequencing 
 
1. REVERSE TRANSCRIPTION AND STRAND-SWITCHING 
a. Transfer 100 ng of prepared RNA into a 1.5 ml Eppendorf DNA LoBind 
Tube 
i. Adjust volume using no greater than 7.5 ul of nuclease-free water 
ii. Mix by flicking tube to prevent shearing and spin down for 5 
seconds in microfuge 
b. Prepare the following in a separate 0.2 ml PCR tube (1) for a total volume 
of 11 ul: 
i. Mix gently by flicking and spin down for 5 seconds in microfuge 
ii. Incubate at 65 C for 5 minutes then cool immediately on a -20 pre-
chilled freezer block 
c. In a separate 0.2 ml PCR tube (2) mix the following for a total of 8 ul: 
i. Mix gently by flicking and spin down for 5 seconds in microfuge 
d. Add the prepared strand-switching buffer from Step 3 to the cooled 0.2 ml 
PCR tube from Step 2 
i. Mix gently by flicking and spin down for 5 seconds in microfuge 
ii. Incubate at 42 C for 2 minutes 
e. Add 1 ul of Maxima H Minus Reverse Transcriptase so the volume is now 
20 ul. 
i. Mix gently by flicking and spin down for 5 seconds in microfuge 
ii. Incubate on a PCR cycler using the following protocol: 
2. RNA DEGRADATION AND SECOND-STRAND SYNTHESIS 
a. Add 1 ul of RNase Cocktail Enzyme Mix to the prepared reverse 
transcription reaction 
i. Incubate for 10 minutes at 37 C 
ii. During this incubation, resuspend the AMPure XP beads by 
vortexing 
b. Transfer the reverse transcription and RNase mix to a new 1.5 ml 
Eppendorf DNA LoBind tube 
c. Add 17 ul of the resuspended AMPure XP beads 
i. Mix by gently flicking the tube 
ii. Incubate on a Hula rotating mixer or rotating by hand for 5 minutes 
at room temperature 
1. During this incubation prepare 500 ul of fresh 70% ethanol 
in nuclease-free water 
iii. Spin down the sample for 5 seconds on a microfuge 
d. Place tube on the magnet and allow a pellet to form 
e. While keeping the tube on the magnet, pipette and discard supernatant 
f. While still on magnet, wash the beads with 200 ul of the freshly prepared 
70% ethanol without disturbing the pellet 
i. Remove ethanol using a pipette and discard 
ii. Repeat previous steps 3. f-i 
iii. Spin down the sample for 5 seconds on a microfuge 
g. Place the tube back on the magnet and allow pellet to form 
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i. Pipette off any residual ethanol 
ii. Allow pellet to dry for no longer than 30 seconds 
h. Remove the tube from the magnetic rack and resuspend pellet in 20 ul of 
nuclease-free water 
i. Incubate on a Hula rotating mixer or rotating by hand for 10 
minutes at room temperature 
i. Place tube on the magnetic and allow pellet to form 
i. Ensure the eluate is clear and colorless 
j. Remove 20 ul of the supernatant and pipette into a new 1.5 ml Eppendorf 
DNA LoBind tube 
k. Prepare the following reaction in a 0.2 ml thin-walled PCR tube for a total 
of 50 ul: 
l. Incubate using the following protocol: 
m. Resuspend the AMPure XP beads by vortexing 
n. Transfer the sample to a clean 1.5 ml Eppendorf DNA LoBind tube 
o. Add 40 ul of the resuspended AMPure XP beads, mix by gently flicking 
tube 
i. Incubate on a Hula rotating mixer or rotating by hand for 5 minutes 
at room temperature 
1. During this incubation prepare 500 ul of fresh 70% ethanol 
in nuclease-free water 
ii. Spin down the sample for 5 seconds in a microfuge 
p. Place tube on the magnet and allow a pellet to form 
i. While keeping the tube on the magnet, pipette and discard 
supernatant 
q. While still on magnet, wash the beads with 200 ul of the freshly prepared 
70% ethanol without disturbing the pellet 
i. Remove ethanol using a pipette and discard 
ii. Repeat previous steps 11. q-i 
iii. Spin down the sample for 5 seconds on a microfuge 
r. Place the tube back on the magnet and allow a pellet to form 
i. Pipette off any residual ethanol 
ii. Allow pellet to dry for no longer than 30 seconds 
s. Remove the tube from the magnetic rack and resuspend pellet in 21 ul of 
nuclease-free water 
i. Incubate on a Hula rotating mixer or rotating by hand for 10 
minutes at room temperature 
t. Place tube on the magnetic and allow pellet to form 
i. Ensure the eluate is clear and colorless 
ii. Remove 21 ul of the supernatant and pipette into a new 1.5 ml 
Eppendorf DNA LoBind tube 
u. Analyze 1 ul of the strand-switched DNA for size, quantity, and quality 
3. END-PREP: END REPAIR AND DA-TAILING OF FRAGMENTED DNA 
a. Mix the following reagents in a 0.2 ml PCR tube for a total of 60 ul: 
i. Mix gently by pipetting and spin down for 5 seconds on microfuge 
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ii. Incubate using a thermal cycler: 20 C for 5 minutes then 65 C for 5 
minutes 
1. During incubation, resuspend the AMPure XP beads by 
vortexing 
b. Transfer the sample to a new 1.5 ml DNA LoBind Eppendorf tube 
i. Add 60 ul of the resuspended AMPure XP beads and mix gently by 
pipetting 
ii. Incubate on a Hula rotating mixer or rotating by hand for 5 minutes 
at room temperature 
1. During incubation prepare 500 ul of fresh 70% ethanol in 
nuclease-free water 
iii. Spin down sample for 5 seconds on microfuge 
c. Place tube on the magnet and allow a pellet to form 
i. While keeping the tube on the magnet, pipette and discard 
supernatant 
d. While still on magnet, wash the beads with 200 ul of the freshly prepared 
70% ethanol without disturbing the pellet 
i. Remove ethanol using a pipette and discard 
ii. Repeat previous steps d-i 
iii. Spin down the sample for 5 seconds on a microfuge 
e. Place the tube back on the magnet and allow a pellet to form 
i. Pipette off any residual ethanol 
ii. Allow pellet to dry for no longer than 30 seconds 
f. Remove the tube from the magnetic rack and resuspend pellet in 21 ul of 
nuclease-free water 
i. Incubate on a Hula rotating mixer or rotating by hand for 10 
minutes at room temperature 
g. Place tube on the magnetic and allow pellet to form 
i. Ensure the eluate is clear and colorless 
h. Remove 30 ul of the supernatant and pipette into a new 1.5 ml Eppendorf 
DNA LoBind tube 
4. ADAPTER LIGATION 
a. Mix the contents of each tube by flicking, check there is no precipitate 
present 
i. Spin down sample for 5 seconds on a microfuge 
b. Perform the adapter ligation process as follows for a total of 100 ul:  
i. Mix by flicking the tube in between each addition 
ii. Spin down for 5 seconds on microfuge 
iii. Incubate the reaction for 10 minutes at room temperature 
5. XP BEAD BINDING 
a. Resuspend the AMPure XP beads by vortexing 
i. Add 40 ul of resuspended AMPure XP beads to the adapter 
ligation reaction from previous step 
ii. Mix gently by pipetting 
iii. Incubate on a Hula rotating mixer or rotating by hand for 5 minutes 
at room temperature 
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b. Place tube on the magnetic rack and allow a pellet to form 
i. While keeping the tube on the magnet, pipette off and discard 
supernatant 
c. Remove tube from the magnetic rack 
i. Add 200 ul of the Adapter Bead Binding Buffer (ABB) to the 
beads 
ii. Resuspend the beads by gently pipetting up and down 
d. Return the tube to the magnetic rack and allow a pellet to form 
i. While keeping the tube on the magnet, pipette off and discard 
supernatant 
ii. Repeat steps d-i 
iii. Spin down the sample for 5 seconds on the microfuge 
e. Place tube on the magnetic rack and allow a pellet to form 
i. While keeping the tube on the magnet, pipette off and discard 
supernatant 
f. Remove the tube from the magnetic rack 
i. Resuspend the pellet in 13 ul of Elution Buffer (EB) 
ii. Incubate on a Hula rotating mixer or rotate by hand for 10 minutes 
at room temperature 
g. Place tube on the magnetic and allow pellet to form 
i. Ensure the eluate is clear and colorless 
h. Remove 13 ul of the supernatant and pipette into a new 1.5 ml Eppendorf 
DNA LoBind tube 
i. Quantify 1 ul of eluted cDNA using a Qubit fluorometer – 
recovery aim ~60 ng 
6. PRIMING AND LOADING THE SPOTON FLOW CELL 
a. Before starting: thaw the Sequencing Buffer (SQB), Loading Beads (LB), 
Flush Tether (FLT), and one tube of the Flush Buffer (FB)/(PFB) at room 
temperature 
i. Place the tubes on ice as soon as thawing is complete 
ii. Mix by vortexing, spin down for 5 seconds in microfuge 
iii. Store on ice 
b. Open the MinION lid and slide the flow cell under the clip 
i. Press down firmly to ensure complete contact is made 
c. Slide the priming port cover clockwise to open the priming port 
d. After opening the priming port, check for air bubbles under the cover 
i. Set a P1000 pipette to 200 ul 
ii. Insert pipette tip into the primer port 
iii. Slowly turn the wheel until you can see a small volume of buffer 
entering the pipette tip 
e. Prepare the flow cell priming mix: 
i. If using EXP-FLP001.PRO.6: add 46 µl of thawed and mixed 
Flush Tether (FLT) directly to the tube of thawed and mixed 
PromethION Flush Buffer (PFB), and mix by vortexing OR  
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ii. If using EXP-FLP002: add 30 µl of thawed and mixed Flush 
Tether (FLT) directly to the tube of thawed and mixed Flush 
Buffer (FB) and mix by vortexing. 
f. Load 800 ul of the priming mix into the flow cell via the priming port 
without introducing air bubbles 
i. Wait for 5 minutes (Do steps g - h at this time) 
g. Mix the contents of the Loading Beads (LB) by pipetting (the beads settle 
quickly to use immediately after mixing) 
h. In a new 1.5 ml tube prepare the following library for a total of 75 ul: 
i. Complete the flow cell priming: 
i. Gently life the SpotON sample port cover 
ii. Load 200 ul of the priming mix into the flow cell via the priming 
port (Not the SpotON sample port) 
j. Mix the prepared library from Step 8 by gently pipetting up and down 
i. Add 75 ul of the sample to the flow cell via the SpotON sample 
port dropwise – ensure each drop flows into the port before adding 
the next 
k. Gently replace the SpotON sample port cover 
i. Ensure the bung enters the SpotON port 
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